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Summary 
Background: Obesity is associated with increased risk for cardiovascular disease, 
type 2 diabetes mellitus, sleep apnea and some cancer types. In women, obesity may 
play a role in the development of polycystic ovary syndrome (PCOS). Obesity 
develops when a human’s energy intake exceeds its energy expenditure, and choice 
of food is an important factor in the development of excessive fat tissue. However, 
the actual diet composition to obese compared to normal weight women are difficult 
to obtain. Reported information about food habits and dietary pattern, tend to be 
misreported, both among lean and obese women. Furthermore, diet, physical activity 
and adipositas status affect risk markers for cardiovascular disease; as dyslipidemia 
and adipokine profile. A common metabolic abnormality in women with PCOS is 
dyslipidemia, and these women also tend to have a more abdominal fat distribution 
than other women, making them more vulnerable for cardiovascular disease. Weight 
reduction and thereby improved body composition, improve the risk factors for 
cardiovascular disease, and might be induced by low-calorie-diets, which consist of 
either traditional food items or meal replacements. 
Method: Part one: Dietary interview, from 116 morbidly obese women and 20 
normal weight control women, based on a FFQ, were utilised in the MOBIL-study. 
The reported food and energy intake among obese women were compared to normal 
weight women, with regard to dietary composition, food choices and accuracy in 
energy intake reporting. Part two: Preliminary results from a randomized controlled 
prospective diet intervention study (FEMIN), including 9 morbidly obese women 
diagnosed with PCOS, where the effect of eight weeks intake of two different low-
calorie-diets; the crisp bread diet and the powder diet, on anthropometric measures, 
body composition, blood pressure, lipid and adipokine profile were investigated.   
Results: Part one: Morbidly obese women had a more unfavourable lipid profile, 
body composition and expression of adipokines compared to the control women. 
Obese women reported almost the same energy and macronutrient intake as normal 
weight women. The intake of fat and saturated fat tended to be higher, while the 
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consumption of alcohol was lower among the obese women than among the control 
women. There were more under-reporters among obese than the normal weight 
women, and the amount of underreported kcal was higher. Part two: Eight weeks on a 
low-calorie-diet lead to significant improvement in anthropometric measures together 
with an improved body composition among women with PCOS.  
Conclusion: Obese women and normal weight controls reported the same energy and 
macronutrients intake; however the intake of fat and saturated fat tended to be higher 
among the obese. Our results may suggest that obese women have a diet consisting of 
more fat containing food items compared to the normal weight women, whose fat 
intake is restricted to fewer particularly fatty food items. Obese women with pre-
PCOS status consumed more potatoes, meat products and forcemeat, butter, 
margarine and oil, light squash/soft drinks and artificially sweetened soft drinks than 
women with lower FTI score. However, since the obese women underreported more 
than normal weight controls, it is difficult to state what the actual differences between 
the diets of obese and normal weight women are. Furthermore, morbidly obese 
women with PCOS have favourable effects of low-calorie-diets, improving several of 
their enhanced cardiovascular risk factors.   
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1. Introduction 
1.1 Overweight and obesity 
Obesity is accumulation of body fat tissue, which interferes with a human beings 
physical and psychosocial health. The World Health Organization (WHO) defines 
overweight as a body mass index (BMI) equal to or greater than 25, while obesity is 
defined as a BMI equal to or more than 30 (weight (kg) / height (m2)=BMI).Globally, 
overweight and obesity are an increasing problem. There are today more than one 
billion adults who are overweight. At least 300 millions of these are obese. This 
increase is attributed to the changes of the society. People are adapting to a more 
sedentary lifestyle, with less physical activity, and easily access to more energy dense 
food. (1). Data from Svensson et al showed that the proportion of obese men and 
women in some parts of Norway have increased from 5 % and 4 % respectively, in 
1990, to 12 % (men) and 11 percent (women) in 2001. At the same time, the 
proportions of people with overweight were increased from 37 % of men and 20 % of 
women in 1990 to 48 % of men and 27 % of women in 2001(2).  In 2007 a meta-
analysis was published on the prevalence of obesity in Norway. The proportion of 
obese men (BMI> 30) in the Norwegian studies from 2000-03 was 11-29% (median 
19.5%), and for women; 9-38% (median 20%). Data from this study also indicates 
that there has been, and still is, an increasing proportion of obese people in Norway 
(3). Obesity is associated with increased risk for cardiovascular disease (CVD), type 
2 diabetes mellitus, sleep apnea and some cancer types (endometrial, breast, and 
colon) (1). Obesity, together with insulin resistance and lipid disorder are factors in 
the metabolic syndrome (4). In women obesity may play a role in the development of 
polycystic ovary syndrome (PCOS) (5). 
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Figure 1. Possible consequences of obesity 
1.2 Diet and development of overweight/obesity 
Overweight and obesity develop when a human’s energy intake exceeds its energy 
expenditure. Lifestyle, environment and genes are all also related to obesity, making 
a complex interaction. However, choice of food is an important factor in the 
development of excessive fat tissue. A report of the joint WHO/FAO expert 
consultation, “Diet, nutrition and the prevention of chronic diseases” from 2003 gives 
recommendations for preventing excessive weight gain and obesity. The report 
focuses on a diet rich in dietary fibre, as well as avoiding intake of high energy-dense 
food. Such foods often contain a lot of fat and sugar and are low in micronutrients 
content (6), just like sugar-sweetened beverages. A greater consumption of sugar-
sweetened beverages is associated with weight gain and obesity (7).  
1.2.1 Diet among Norwegian men and women 
In 1999 a report from a nationwide dietary assessment from 1997 among a 
representative selection of Norwegian men and women aged 16-79 years was 
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published (the Norkost Survey). The mean energy intake (EI) among men and 
women were 2600 kcal and 1920 kcal respectively. Women had a higher energy 
percent from protein and carbohydrate than men. Men had higher energy percent 
from total fat, monounsaturated fat and polyunsaturated fat and alcohol than women. 
According to the official recommendations in Norway, the intake of both fat and 
sugar in men and women were close to the maximal recommended level. The 
recommended intake of maximum ten energy percent from saturated fat were 
exceeded in both groups(8). The intake of dietary fibre was lower than recommended 
(as in the Nordic Nutrition Recommendations 2004 (9)), among the women. 
Table 1. Data from the Norkost Survey 1997, describing the general intake 
of energy and macronutrients in the Norwegian population, and among men 
and women, aged 16-79 years. Bold numbers indicate statistically 
significant difference in intake between men and women, compared with t-
test (p<0.05) (modified) (8). 
  
Total 
(n=2672) 
Men 
(n=1298) 
Women 
(n=1374) 
Energy intake (kcal) 2250 2600 1920 
Protein intake (g) 86 99 74 
Fat intake (g) 79 93 66 
   -saturated fat (g) 31 36 27 
   -monounsaturated fat (g) 28 33 23 
   -polyunsaturated fat (g) 14 17 12 
Carbohydrate intake (g) 284 327 244 
   -sugar intake (g) 56 66 46 
Alcohol consumption (g) 6 8 4 
Dietary Fibre intake (g) 23 25 21 
Share of energy intake     
Protein intake (%) 15.9 15.7 16.2 
Fat intake (%) 30.6 30.9 30.4 
   -saturated fat (%) 12.1 12.1 12.2 
   -monounsaturated fat (%) 10.8 11 10.7 
   -polyunsaturated fat (%) 5.4 5.6 5.2 
Carbohydrate intake (%) 51.6 51.1 52.1 
   -sugar intake (%) 9.3 9.5 9.1 
Alcohol consumption (%) 1.8 2.2 1.4 
 
Men ate more of most of the food items, while women had a significant higher intake 
of vegetables, fruits and berries, skimmed milk, tea and wine than men. Among the 
1319 participating women in this assessment, 549 women were aged between 20-39 
years, having a mean BMI of 23.1. Of the women aged 20-29 (n=263) 13 % and 4% 
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were overweight and obese respectively, while in the group of women aged 30-39 
(n=286) 20 % were overweight, while 7 % were obese (8).  
1.2.2 Diet among obese women 
Recently, Savage et al investigated the energy density (ED) and food choices among 
186 white women in Pennsylvania, USA. They grouped the participants into three 
groups based on the energy density in their diet. Women having a low energy density 
diet ate more water-rich foods as fruits and vegetables, while they had lower intake of 
grains. They had fewer servings of bread, baked desserts and refined products 
compared to the high energy density group, which again consumed less whole grains 
than the low energy density group. Women in the high ED group reported higher 
consumption of French fries and potato chips compared to the low energy density 
group which reported higher intake of dark green, yellow and red vegetables. Women 
in the low ED group gained less weight than in women in the high ED group over six 
years (10). Schulze et al examined women in the Nurses’ Health Study II and their 
dietary patterns over a period of time. Findings from this cohort suggested that a diet 
characterized by high intakes of red and processed meats, refined grains, sweets, 
desserts and potatoes may contribute to a greater weight gain than a dietary pattern  
consisting of a lot of fruits and vegetables, whole grains, poultry, fish and salad 
dressing (based on oil and vinegar). The latter diet may result in weight maintenance 
(11).  
1.3 Cardiovascular disease 
Cardiovascular disease is a collective term which includes coronary heart disease 
(CHD), hypertension, cerebrovascular disease, peripheral artery disease, rheumatic 
heart disease, congenital heart disease and heart failure. In 2005 approximately 17.5 
million people died from cardiovascular disease globally, making CVD the number 
one cause of death (12). The largest epidemiologic study of cardiovascular disease in 
the world is the Framingham Heart Study. There are seven major risk factors for 
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CVD identified by the Framingham study; age, sex, blood pressure, total and high-
density lipoprotein cholesterol (HDL-C), smoking, glucose intolerance, and left-
ventricular hypertrophy. However in the Framingham studies, obesity has not been 
identified as a risk factor for CVD (13-16). Environmental risk factors predisposing 
to CVD are among others physical inactivity, obesity and unhealthy diet (12;17;18). 
The INTERHEART study identified nine important risk factors for myocardial 
infarction; abnormal lipids, abdominal obesity, diabetes, smoking, hypertension, 
psychosocial factors, intake of fruit, vegetables and alcohol and regular physical 
activity. The same risk factors were identified for both sexes and at all ages (19).  
1.3.1 Lipids and lipoproteins 
Cholesterol is a lipid with several physiologically functions. It is a precursor for bile 
acids and steroid hormones, as well as an important constituent of the cell membrane. 
In the blood, cholesterol is transported in particles consisting of lipids and proteins, 
called lipoproteins. There are three main lipoprotein particles in serum – very low 
density lipoproteins (VLDL) (secreted by the liver), low density lipoproteins (LDL) 
and high density lipoproteins. Lipids travel in the blood as triglycerides incorporated 
in the lipoproteins. A proportion of the triglycerides are also free in serum. Heritage, 
diet, physical (in)activity, obesity and smoking are some of the factors which affect 
the levels of cholesterol in the body (20-22). The recommended concentration of total 
cholesterol and LDL-C in plasma in persons without disease is below 5.0 mmol/l and 
2.5 mmol/l respectively. Triglyceride values below 1.7 mmol/l are recommended. For 
both men and women, the National Cholesterol Education Program (NCEP) in USA, 
defines a categorical low HDL-C as less than 1.0 mmol/l. High levels of HDL-C is 
classified as more than 1.55 mmol/l (17;20). 
Subclasses of lipoproteins and apolipoproteins 
Low density lipoproteins 
There are different subclasses of the lipoproteins. There are several subspecies of low 
density lipoproteins, based on the size and density. The main fractions are the large 
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and more buoyant, and the small and more dense particles. The last mentioned has 
more atherogenic properties than the large LDL particles (23;24). LDL particles 
contain a protein; apolipoprotein B 100 (apoB), and it serves as a receptor ligand. 
Apolipoprotein B 100 is produced in the liver and incorporated into VLDL, which is 
then transformed to LDL during the metabolism (22). 
High density lipoproteins 
Reverse cholesterol transport is one of the main tasks for HDL particles, making it 
the “good cholesterol”. They transport excess cholesterol from peripheral cells to the 
liver for excretion (25). HDL particles have other properties as well, contributing to 
its antiatherogenic effect. It serves as an antioxidant and an anti-thrombotic molecule. 
(26). HDL-particles are also associated with apolipoproteins; apoA-I and/or apoA-II 
(20).   
1.3.2 Atherosclerosis 
Atherosclerosis is an inflammatory disease in the arteries, causing cardiovascular 
disease. This is a formation of lesions in the arteries that is characterized by 
inflammation, lipid accumulation, cell death and fibrosis. At the initiation these 
plaque are called fatty streaks (27). The major cellular events contributing to these 
fatty streaks are the diffusion of LDL-cholesterol through dysfunctional endothelium 
into the subendothelial space, and the subsequent recruitment of macrophages 
(28;29). Subsequent LDL oxidation and enzymatic modifying in the intima layer, 
form new molecules of LDL, like oxidized LDL. The macrophages have scavenger 
receptors which mediate the uptake of oxidized LDL. The accumulation of lipid 
droplets inside the macrophage turns it into a foam cell. With time the lesions can 
disappear, or they can mature and gain new characteristics. They are then called 
atherosclerotic plaques. (27). An intact endothelium covers the plaque. Progressive 
development of the atherosclerotic plaque narrows the vessel lumen and results in 
ischemic symptoms. Major complications occur if the endothelium ruptures. 
Exposure of subendothelial material to the vascular lumen promotes blood platelet 
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aggregation and thrombus formation. A thrombus might occlude the artery, leading to 
acute ischemia (27-29).    
 
Figure 2. The development of the atherosclerotic plaque, modified from 
Dahl et al (30). 
1.3.3 Risk factors for atherosclerosis and cardiovascular disease 
Dyslipidemia 
Dyslipidemia is characterized by increased levels of VLDL- and LDL cholesterol in 
the blood. The triglycerides are often raised and the HDL-C is decreased. 
Hypercholesterolemia, hypertriglyceridemia together with low levels of HDL-C can 
occur one by one or all together. Obesity, diabetes mellitus type 2, high intake of 
saturated fat and alcohol, and physical inactivity may lead to increase in plasma 
cholesterol and triglycerides (21). Atherosclerotic vascular disease is linked to 
elevated levels of cholesterol in the blood. A reduction of LDL-C by 1 mmol/l has 
been estimated to give a 23 % reduction in first major coronary events. Furthermore, 
a 10 percent reduction of total cholesterol is accompanied by a 25 % reduction of 
incidence of cardiovascular disease after 5 years (31;32).  HDL-C less than 1.0 
mmol/l for men and 1.2 mmol/l for women ,and fasting triglycerides over 1.7 mmol/l 
may also serve as markers of increased cardiovascular risk (32). The Framingham 
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study found that decreased levels of HDL-C increases the risk for coronary heart 
disease (33). Higher levels of HDL-C are associated with reduced risk (20).  
Subclasses of lipoproteins  
The presence of small, dense LDL particles together with decreased HDL-C and 
increased triglycerides have been associated with a three-fold increased risk for 
coronary heart disease (34).  
Ratio between the apolipoproteins 
There is growing evidence that the ratio between apolipoprotein B and apolipoprotein 
A-I can be predictive in the estimation of cardiac risk. Walldius et al showed that the 
values for apoB and apoB/apoA-I were positively and strongly related to increased 
risk of fatal myocardial infarction in both men and women. In multivariate analysis, 
apoB was a stronger predictor of risk than LDL-C in both sexes (35).  
C-Reactive Protein (CRP) 
This is as acute phase protein which is synthesised in the liver and released in 
response to inflammation. CRP is a potential inflammatory marker for cardiovascular 
risk, and CRP levels may predict CVD in apparently healthy individuals. Since 
atherogenesis (the process of development of atherosclerosis) is an inflammatory 
response to many different risk factors (as raised LDL-C), CRP has been shown to be 
elevated, independently of other risk factors. Subjects with concentrations of CRP 
above 3.0 mg/L are regarded as having a higher risk for subsequent cardiovascular 
disease. Obesity, which also is an inflammatory state, produce elevations in CRP, but 
weight loss have been shown to lower the CRP level in blood (17;36).   
Obesity 
Adipose tissue serves as an energy depot, located in the body. The distribution of 
body fat is important in the development of different diseases, like diabetes, 
atherosclerosis and coronary heart disease. Upper-body obesity (android) is more 
likely to be associated with these diseases than lower-body obesity (gynoid). Upper-
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body fat, as abdominal fat distribution, includes both the visceral fat, which encircle 
the internal organs, and the subcutaneous depots. The latter depot is situated below 
the skin in the abdominal region. Lower-body fat consists only of subcutaneous 
adipose depots, lying immediately under the skin, especially in the gluteal and 
femoral regions (37). 
Visceral fat is metabolically very active, having high rates of lipogenesis and 
lipolysis. These processes result in release of free fatty acids to the circulation, which 
again may cause increased lipid synthesis in liver and insulin resistance. This may 
result in hyperlipidemia, glucose intolerance and hypertension, all of which are risk 
factors for atherosclerosis. Suggested factors for visceral fat accumulation are aging, 
disturbances of sex hormones, overconsumption of sucrose and physical inactivity. 
(38). A simple way to predict the amount of visceral fat is to use the anthropometric 
measure of waist circumference (W.C.), which has been shown to be positive 
correlated to the visceral fat mass (FM) (39). The waist circumference is not enough 
to diagnose visceral obesity, but together with raised levels of fasting triglycerides, 
may represent a simple marker of excess visceral fat (40). Excessive upper-body fat 
can be measured by an increase in waist-to-hip ratio (WHR). The cut off value for the 
waist-to-hip ratio is 0.85 in women and 1.0 in men, where higher ratios indicates 
increased upper-body fat (41). 
To detect a subject’s body composition, the use of Bioelectrical Impedance Analysis 
(BIA) is an applicable method. Different tissue in the body differ in their way to 
conduct bioelectrical impedance, and in this way the BIA can analyse the percentage 
of fat mass, fat free mass (FFM) and body water in the body. Ozenolgu et al have 
recently described that increasing BMI is associated with higher percentage of body 
fat, while the amount of lean body mass and body water decrease (42). In normal 
weight women, 21-35 % of the body weight is contributed by fat tissue (43). In obese 
and morbidly obese women the fat mass have been shown to constitute 35 and 40 % 
respectively, of the body weight (42).     
 26 
The adipose tissue is also a secretory organ. Increase of adipose tissue lead to altered 
production and secretion of adipokines which is a collective term for chemokines, 
cytokines and hormone-like proteins. These substances affect virtually all organ 
systems in the body. The adipokines have either systemic or local effect, and they are 
implicated in metabolic and inflammatory processes. Energy homeostasis, adipocyte 
differentiation, insulin sensitivity, control of inflammation, vascular inflammation 
and neo-angionesis are all affected by these substances (44;45). The abdominal 
visceral adipose tissue seems to be the most unfavourable, due to the great secretion 
of these substances, especially affecting the cardiovascular system (40;45).  
Metabolic syndrome 
The metabolic syndrome includes a cluster of metabolic disturbances, and was 
defined by the WHO in 1998. Later, new criteria have been proposed. The 
International Diabetes Federation released in 2006 a new consensus statement on the 
definition of the syndrome. In the new definition, central obesity is important. For a 
person to be defined as having the metabolic syndrome, he/she must have a waist 
circumference over a specific value (for Europeans; males > 94 cm, females > 80 cm) 
plus any two of four additional factors; raised blood pressure (systolic: ≥ 130 mmHg 
or diastolic: ≥ 85 mmHg, or treatment of previously diagnosed hypertension), 
increased values of triglycerides (≥1.7 mmol/l), reduced HDL-C (< 1.03 mmol/l in 
males and < 1.29 mmol/ l in females) and/or raised fasting plasma glucose (fasting 
plasma glucose ≥ 5.6 mmol/l or previously diagnosed type 2 diabetes)  (4). The 
International Diabetes Federation criteria lowered the cut off values for the waist 
circumference and made this parameter essential in the definition of the metabolic 
syndrome compared to the previous definition of the syndrome made by the National 
Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). In this 
definition the criteria of waist circumference were higher (males > 102 cm, females > 
88 cm) and equalised with the other criteria, where having three out of the five 
criteria was enough to be defined with the metabolic syndrome (20).  
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Figure 3. Definition of the metabolic syndrome from the International 
Diabetes Federation (2006)(4), see details in text.  
Adipokines – Leptin and adiponectin 
Leptin 
Adipokines are secreted by the adipose tissue, and they are involved in the regulation 
of metabolic homeostasis. Leptin circulates in the body influencing the regulation of 
energy stores and energy balance. One site of action is the central nervous system 
where it affects the expression of molecules that influence the feeling of hunger and 
satiety. Leptin inhibits orexigenic peptides, thereby reducing appetite and subsequent 
food intake, and hamper peptides which decrease energy expenditure (46-48). The 
concentration of plasma leptin is dependent of the amount of energy stored as fat and 
also the energy balance. Obese persons have increased levels of leptin, but the 
mechanism behind this is debated. It is not evident if this increase are due to the 
increased adipose tissue itself and thereby increased release, or if the body develops a 
central leptin resistance, which leads to increased levels of leptin in plasma (46;47).  
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Figure 4. Action of leptin in the regulation of energy balance. 
Adiponectin 
Adiponectin is also secreted by adipose tissue, and it plays a role in the lipid and 
glucose homeostasis. In the liver, adiponectin decreases glucose production and lipid 
synthesis (49). In other tissues, this circulating protein influences the basal glucose 
level, decreasing it transiently (50). In addition, adiponectin affects muscle tissues, 
increasing tissue fat oxidation and reducing triglyceride production, thereby lowering 
the triglyceride concentration in tissues. Decreased levels of triglycerides may 
enhance insulin sensitivity, or adiponectin may increase the insulin sensitivity of the 
hepatocytes by the direct action on the liver (49). Thus, adiponectin may have a role 
in preventing or counteracting the development of insulin resistance. Although 
adiponectin is secreted from adipose tissue, obese persons have lower concentrations 
of this parameter in plasma than normal weight persons (49;51). Adiponectin have 
further been associated with dyslipidemia; and is negatively correlated with 
triglycerides and apolipoprotein B-100, and a positively correlated with HDL-C (51). 
Weight loss in obese persons has been shown to increase the concentration of 
adiponectin in plasma (52). Adiponectin may also have an anti-inflammatory and 
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anti-atherogenic function (49;51). Recent studies have reported that different adipose 
tissues have unequal capacity to secrete adipokines. Subcutaneous adipose tissue has 
been shown to produce leptin, while visceral fat is the major production site of 
adiponectin (53). 
 
Figure 5. Action of adiponectin on adipose tissue and peripheral organs 
(liver, blood and skeletal muscle). Adapted from Meier et al (49). 
Insulin resistance 
Raised fasting plasma glucose can be caused by resistance to the effects of insulin on 
glucose uptake, metabolism or storage (54). Insulin is secreted from the islet β-cells 
in pancreas due to increasing concentrations of glucose in the blood. Insulin is 
essential in the process where glucose is transported into the cells.  Some people are 
lacking production of insulin. They have diabetes mellitus type 1. Other people show 
resistance and low sensitivity to the insulin which is produced in their body and 
become insulin resistant. When this development starts, the pancreas will increase the 
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production of insulin and thereby overcome the reduced efficacy of insulin action. 
Normal glucose tolerance is maintained. When the tissues are getting more insulin 
insensitive and pancreatic insulin production no longer can overcome this, the person 
becomes insulin resistant and will develop hyperglycaemia. Adipocytes also express 
insulin resistance, and as a consequence lipolysis is enhanced, increasing the 
concentration of free fatty acids in plasma (55).  Insulin sensitivity is affected by 
several factors like obesity, physical activity and fitness (56) 
1.4 Polycystic ovary syndrome  
1.4.1 Diagnosis 
Polycystic ovary syndrome is a syndrome of ovarian dysfunction, characterized by 
hyperandrogenism, polycystic ovaries, and chronic oligo-anovulation. Clinical 
manifestations may be infertility, menstrual irregularities, signs of androgen excess 
and obesity. The diagnostic criteria for PCOS, which were revised in 2003, are (two 
out of three of the following criteria) 1) oligo- and/or anovulation 2) clinical and/or 
biochemical signs of hyperandrogenism and 3) polycystic ovaries. Other medical 
conditions that may cause irregular menstrual cycles and androgen excess must be 
excluded (57).  
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Figure 6. The diagnostic criteria for PCOS are (two out of three) 1) oligo- 
and/or anovulation 2) clinical and/or biochemical signs of 
hyperandrogenism and 3) polycystic ovaries. 
1.4.2 Prevalence of polycystic ovary syndrome 
Polycystic ovary syndrome is a common endocrine disorder among reproductive-
aged women. Though the data is scarce on the prevalence of PCOS among 
overweight or obese women, there seems to be a trend that many women  with PCOS 
tend to be overweight or obese (5) . A study of overweight and obese Spanish women 
demonstrated a prevalence of PCOS of 28 percent (58). Recently Yildiz et al 
described the prevalence of PCOS among overweight and obese premenopausal 
females in Birmingham, Alabama to be 9.9% and 29.2%, respectively. By using the 
obesity classes (class 1: BMI 30-35, class 2: BMI 35-40, class 3: BMI>40) they 
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reported an increasing proportion of women diagnosed with PCOS in relation to 
higher obesity classes. The researchers further described the prevalence of obesity 
among PCOS patients diagnosed between 1987 and 2002. In 1987-1990 the 
prevalence of obesity in PCOS patients was 51%, and increasing to 74% in 2000-
2002. However, they indicated that the risk for PCOS is only slightly increased in 
obese women, although the proportion of obese women with PCOS has increased. 
This increase in PCOS may be similar to the increase of obesity seen in the general 
population (59). On the other hand, PCOS has also been shown in normal weight 
women, where the prevalence of PCOS is estimated to be between 4 and 10 percent 
(59-62). 
1.4.3 Clinical features of PCOS 
Ultrasound is used to diagnose polycystic ovaries by assessing follicle number and/or 
ovarian volume. The polycystic ovary should have 12 or more follicles, each 
measuring 2-9 mm in diameter, or increased ovarian volume (>10cm3) (63). 
Clinical signs of chronic anovulation are either oligomenorrhoea or amenorrhoea. 
Oligomenorrhoea is defined as less than eight menstruations per year, or cycles that 
are longer than 35 days. Amenorrhoea is absence of periods for more than three 
months, without pregnancy (64).  
Hyperandrogenism has cutaneous manifestations like hirsutism, acne and female-
pattern alopecia. Hyperandrogenemia can be proven biochemically by measuring 
serum total testosterone (T) and sex hormone binding globulin (SHBG), with 
subsequent calculation of the free testosterone index (FTI). The reference value for 
FTI among women is 0.1 – 0.6. Women with PCOS have FTI scores around 1 
(65;66). Since the reference value is up to 0.6, a FTI score above 0.6 may indicate the 
beginning of a PCOS diagnosis. Women with FTI > 0.6 can be classified as pre-
PCOS subjects.   
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Women with PCOS have increased risk of developing dyslipidemia, cardiovascular 
disease, endometrial carcinoma and also type 2 diabetes, due to insulin resistance and 
hyperinsulinemia  (66-69).  
1.4.4 Adipose tissue distribution in women with PCOS 
There is increasing evidence that the distribution of body fat among women with 
PCOS is abnormal, and that these women tend to have a more abdominal fat 
distribution than women without PCOS (70;71). Furthermore, visceral fat have been 
shown to be the most significant variable to correlate with metabolic disturbances 
seen in women with PCOS (5;39). Carmina et al reported that overweight and normal 
weight women with PCOS had similar amounts of total and trunk fat, but they had a 
higher proportion of central abdominal fat, compared to normal age-and-weight-
matched controls. However, obese women with PCOS did not show this difference 
compared to obese controls, all the fat parameters were the same, though increased. 
PCOS patients with increased central abdominal fat had significantly higher 
concentrations of insulin levels and lower insulin sensitivity. Also the PCOS women 
without excessive central abdominal fat had the same disturbance in the insulin 
balance compared to matched controls (72). Another study comparing non-obese 
(BMI < 25) PCOS women with lean control women found that the women with 
PCOS had significantly higher proportions of preperitoneal and visceral fat than the 
control women, while the distribution of subcutaneous fat was similar for both 
groups. The HDL-concentration was inverse correlated with the intra-abdominal fat, 
while the triglyceride levels correlated positively (73).  Excess central fat 
accumulation in PCOS women have been shown to be associated with the low-grade 
inflammation and the insulin resistance in these women, independent of the PCOS 
diagnosis (74).    
Cussons et al investigated the prevalence of metabolic syndrome in women with 
PCOS and found that there is an approximately four times increase in the incidence 
of the metabolic syndrome in women with PCOS compared to the general population. 
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The estimate will vary according to different diagnostic criteria of PCOS and the 
metabolic syndrome, as well as different ethnicity (75).  
1.4.5 Dyslipidemia in PCOS women 
Dyslipidemia is appointed as a common metabolic abnormality in women with 
PCOS, but the extent of and type of dyslipidemia are reported differently. 
Dyslipidemia characterised by elevated triglyceride levels and small, dense LDL 
particles as well as lower concentration of HDL-C have been reported (68;76). A 
cross sectional study from Glasgow found that women diagnosed with PCOS had 
higher concentrations of triglycerides and VLDL-cholesterol. The same women also 
had higher concentrations and proportion of the atherogenic, small and dense LDL 
compared to BMI-matched controls. They found no differences in total cholesterol, 
LDL-C and HDL-C between the groups (77). Talbott et al demonstrated that women 
with PCOS, under the years of 45, had higher LDL-C compared to controls, after 
adjustment for insulin levels, BMI and hormone use. Little difference was however 
detected between PCOS-cases and controls over the age of 40 years (78). Contrary to 
this, Holte et al did not find any significant differences in serum concentrations of the 
major serum lipoprotein lipids when comparing lean and obese patients with PCOS 
with lean and obese controls. Obese cases with PCOS showed similar abnormal lipid 
profile as obese women without PCOS, even though the PCOS women had 
significantly reduced insulin sensitivity and glucose tolerance (79). However, Legro 
et al observed that both obese and non-obese women with PCOS had significantly 
higher levels of total cholesterol and LDL-C compared with BMI-matched controls. 
The obese PCOS women also had significantly greater HDL-cholesterol and 
triglyceride levels than the obese control women. When they adjusted for age and 
BMI, the levels of HDL-C were higher among all the women with PCOS compared 
to controls. Furthermore, when the researchers adjusted for age, BMI, waist-to-hip 
ratio and fasting insulin and glucose levels, the levels of LDL-C  were still 
significantly higher in the PCOS women, while the levels of HDL-C and triglyceride 
were still increased, but no longer significantly increased compared to the controls 
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(80). Recently, a study comparing thirty overweight PCOS women with twenty-four 
matched control subjects found higher concentrations of plasma triglycerides and 
lower levels of HDL-C among the women with PCOS. In this study there were no 
difference in total cholesterol and LDL-C, but fourteen of the patients with PCOS had 
smaller and more atherogenic LDL particles than the controls. This was the second 
most common lipid alteration after the decreased HDL-C (81). In conclusion, a 
majority of studies indicate that women with PCOS have an atherogenic lipoprotein 
profile, characterized by elevated levels of triglycerides, increased levels of small 
dense LDLs and depressed concentration of HDL-C.    
1.4.6 Expression of adipokines in women with PCOS 
Leptin levels have been investigated in women with PCOS and have been related to 
BMI rather than other metabolic or hormonal disturbances in PCOS (82). Leptin 
levels increases with increasing BMI for obese women both with and without PCOS 
(83). Studies of obese women with polycystic ovary syndrome have reported 
significantly lower levels of adiponectin in these women compared to weight-
matched controls (83;84). Increasing BMI and waist circumference have been shown 
to be negatively correlated to adiponectin levels for obese women both with and 
without PCOS (83;85). In addition, Spranger et al explored that circulating levels of 
adiponectin was independently correlated to the degree of insulin resistance in PCOS 
women, and may contribute to the development and/or maintenance of insulin 
resistance independently from adiposity (85).  
1.4.7 PCOS and cardiovascular disease 
Women with polycystic ovary syndrome tend to hold shares of many of the 
cardiovascular risk factors, like obesity, insulin resistance and dyslipidemia (67;86). 
Studies of PCOS women have discovered altered function and structure of the 
cardiovascular system in these women, which mainly have been described as a 
consequence of the risk factors mentioned earlier, rather than to the presence of 
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PCOS per se (76). Recently, asymptomatic coronary atherosclerosis (using coronary 
artery calcium as a marker) was detected in young obese women with PCOS, and this 
group had a significantly higher prevalence of coronary atherosclerosis compared to 
young, obese controls. The risk for subclinical coronary atherosclerosis was 
independent of other known risk factors for cardiovascular disease (87). Furthermore, 
the increased distribution of visceral fat in PCOS women is shown to be correlated 
with elevated carotid artery intima-media thickness, and reduced flow-mediated 
dilation. These two parameters are predictors of vascular health (71). Young normal 
weight and overweight girls with PCOS have been examined, and increased carotid 
intima-media thickness and reduced flow-mediated dilation are common features, 
suggesting that the vascular wall is affected, leading to premature subclinical 
atherosclerosis and vulnerability to cardiovascular disease later on in life (88;89).  
A retrospective cohort study of women diagnosed with PCOS before 1979 was 
conducted in United Kingdom in 1999, where they wanted to explore the prevalence 
of cardiovascular disease. Despite elevated prevalence of several cardiovascular risk 
factors in the PCOS women, the researchers did not find increased history of 
coronary heart disease in these PCOS women compared to the controls (90). Solomon 
et al used material from the Nurses’ Health Study, and examined the relationship 
between irregular menstrual cycles and coronary heart disease. Fourteen years after 
they had stated their menstruation pattern, women with usually irregular or very 
irregular menses (a reasonable surrogate for the presence of PCOS) were compared to 
women with regular menstrual cycles. Adjusted for age, those who had had usually 
irregular and very irregular menstruations had increased relative risk (RR 1.25 and 
1.67) for nonfatal and fatal coronary heart disease. Adjusting for BMI; higher BMI 
was associated with greater risk for the development of CHD (91). However, there 
are too few good epidemiological studies about PCOS and cardiovascular disease, 
thus definitive evidence for an increased incidence of CVD among women with 
PCOS is lacking (76).   
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CRP in PCOS women 
The levels of CRP in women with PCOS are reported to be increased compared to 
age- and weight-matched controls (71). However, some studies also report that obese 
women with PCOS have similar concentrations compared to obese controls. It has 
been shown that obese PCOS women have CRP values above 3 mg/L, which 
indicates a higher risk of cardiovascular disease in these women (67). The association 
of increased CRP levels in PCOS women may be dependent upon the co-existent 
obesity, rather than the PCOS diagnosis per se (76). A recently published study 
concluded that both PCOS and obesity contribute to a proatherogenic state (with 
increased CRP among other factors), but in women with PCOS, abdominal adiposity 
and hyperandrogenism may exacerbate the risk for atherosclerosis (92).  
1.5 Weight reduction  
Obesity and its complications are, as mentioned, associated with increased risk to 
develop different diseases. Thus, there is evidence that weight loss reduces the risk 
factors for both cardiovascular disease and diabetes (93), and can prevent the 
development of different cancers (94). Weight reduction leads to lowered levels of 
triglycerides, higher concentrations of HDL-C and some reduction in total cholesterol 
and LDL-C. Weight loss also results in reduced blood pressure and lower levels of 
blood glucose (41;93). Furthermore, the “Clinical Guidelines on the Identification, 
Evaluation, and Treatment of Overweight and Obesity in Adults” recommends that 
the initial goal of weight loss therapy should be to reduce the body weight by 
approximately 10 percent from the weight at baseline (93). A successful weight loss 
is defined as loosing at least 10 percent of the initial body weight and maintain this 
weight reduction for at least one year (95). 
Weight loss and diet 
One way to achieve weight loss is to reduce the intake of energy from the diet to a 
lower level than the body needs to keep the machinery going. Diets with an extremely 
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low calorie intake are called very-low-calorie diets, while diets with higher calorie 
content, though they are still low in energy, are named low-calorie diets. Today, there 
is not enough evidence to conclude what kind of diet regimen a person should use to 
loose weight. There are many different regimens, and there is an ongoing debate 
discussing which one of them will make the greatest weight loss, improve the body 
composition in the most favourable way and lead to a better health status generally. 
The different diet regimens differ in the amount of carbohydrate, fat and protein, 
some being low in one macronutrient and very high in another (96-98). Recently, 
Sacks et al published a study on the effect on weight reduction of four different 
weight-loss diets composited of different amounts of fat, protein and carbohydrates. 
645 participants completed the two years study. The nutrient goals for the four diet 
groups were: #1: 20% fat, 15% protein and 65% carbohydrates (low-fat, average-
protein), #2: 20% fat, 25% protein and 55% carbohydrates (low-fat, high-protein), 
#3: 40% fat, 15% protein and 45 % carbohydrates (high-fat, average-protein) and #4: 
40% fat, 25% protein and 35% carbohydrates (high-fat, high-protein). Each 
participant was instructed to eat 750 kcal less than their estimated total energy 
expenditure (eTEE). The participants were followed-up by regularly group- and 
individual sessions. All diets were successful in causing weight loss regardless of 
which macronutrients they emphasized. The degree of weight loss was strongly 
associated with the attendance to the group- and individual sessions (99).  
Body composition after weight loss 
During a period of weight reduction, the body utilize energy from its stored energy 
compartments, due to the insufficient energy intake.  The body uses energy stored in 
the fat compartments, but may also utilize energy stored in muscle tissue. Loss of fat 
free mass (muscle mass) is unfavourable, since these tissues are responsible for the 
majority of the resting metabolic rate (RMR) (see section 1.6.3), regulation of core 
body temperature and maintenance of function in the body (100). A review over 
dietary weight interventions revealed that weight loss induced by low-calorie-diets 
(LCD) or very-low-calorie-diet (VLCD) alones, led to weight losses where 14% and 
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23.4 % of these weight losses were constituted by fat free mass. Among subjects on 
LCD without exercise, a higher proportion of their weight loss were fat free mass, 
compared to the subjects who had engaged in exercise (100). Recently, Chaston et al 
reviewed the literature with regard to different weight loss interventions and the 
percentual decrease in visceral versus subcutaneous adipose tissue in the abdominal 
region. Since the visceral fat has known unfavourable characteristics, a weight 
reduction program addressing particular loss of this fat depot will be of interest. The 
researchers did not find any compelling evidence for a diet preferentially targeting the 
visceral fat. However, they found that there are signs of an association between 
preferential loss of visceral fat with modest weight loss, and that the effect is 
attenuated with greater weight loss (101).  
Janssen et al investigated the effect of an energy-restricted diet on adipose tissue and 
skeletal muscle tissue, together with or without exercise among obese women. After a 
weight reduction period they found significant reduction in total body weight, total 
adipose tissue and reduced waist circumferences among the participants. The groups 
who had diet and exercise together did not lose skeletal muscle, while the group who 
had diet intervention alone lost skeletal muscle (102). Furthermore, the same 
researchers detected that the weight loss among obese women were associated with 
reductions in the levels of total cholesterol, LDL-C and apolipoprotein B (103).   
Weight loss in women with PCOS 
Andersen et al showed in 1995 that among women with PCOS eating a very-low-
calorie diet (~ 420 kcal/day) for four weeks reduced their weight significantly 
(median 9%), and improved their insulin sensitivity (104). Moran et al studied the 
difference  in weight reduction between two diets with approximately 1400 kcal/day, 
one with high protein content (30% protein, 40 % carbohydrate), and the other with 
low protein content (15% protein, 55% carbohydrate). Women with PCOS followed 
one of these diets for 12 weeks. Mean weight loss for both groups was 7.7 kg, with a 
total reduction of 14 % in total fat mass, and 12.5% decrease in abdominal fat mass. 
Independently of the diets, total cholesterol, triglycerides and LDL-C decreased. 
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HDL-C decreased on the low protein diet, but remained unaltered on the high protein 
diet (105). A study in Jordanian PCOS woman found that an energy-restricted diet 
lead to improved clinical and hormonal characteristics of these women (106). A 
recent published study examined the difference in weight loss among women with 
PCOS after an energy-reduced diet supplemented with powder supplements, 
providing 240 kcal, either containing sugar-free whey protein isolate or simple 
sugars. The group consuming the extra protein lost more weight than the “simple 
sugar group”. Fat mass reduction was also greater in the “protein group”, and a 
greater decrease in adiponectin concentrations was also observed. Total cholesterol, 
apo B and HDL-C levels were significantly reduced after two months in the “protein 
group”, but these parameters did not change significantly in the “simple sugar 
group”. There was significant difference in these parameters between the “protein 
group” compared to the “simple sugar group” (107).  
Figure 7. Cartoon from www.glasbergen.com 
Meal replacements and fructose  
One way to accomplish a VLCD or a LCD is to use meal replacements, and replace 
either all or some of the meals during the day with these products. There are different 
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meal replacements available on the market, ranging from bars, soups and shakes. 
Some replace one or two meals during the day with such products, while others only 
use these meal replacements during a certain period of time. Many of the available 
products consist of a considerably amount of mono- and disaccharides, where 
fructose is one of the main ingredients. High intake of fructose has been suggested to 
have an important participatory role in the expansion of the global obesity epidemic, 
and the development of hypertension, diabetes, metabolic syndrome and 
cardiovascular disease among others (108). Teff et al discovered in 2004 that high 
intake of fructose influences negatively the levels of insulin and leptin, which may 
therefore interfere with appetite regulation and calorie intake, and may affect the long 
term regulation of energy homeostasis, thus leading to increased weight. 
Furthermore, fructose intake may give prolonged elevation of triglycerides in plasma 
compared to similar intake of glucose (109).  Recently, Stanhope et al assessed the 
relative effects of consuming either glucose- or fructose-sweetened beverages, 
providing 25 % of the energy requirements for ten weeks, in overweight and obese 
persons. The results suggested that a high intake of fructose may lead to increased 
hepatic de novo lipogenesis, promote dyslipidemia, decrease insulin sensitivity and 
enhance the visceral adiposity in overweight or obese subjects (110). 
Meal replacements and soy protein 
The source of protein in meal replacements differ between the available products. 
Many of these products use soy protein as the protein source. Soy protein intake may 
have effects on serum lipids, as shown by a meta-analysis done by Anderson et al. 
They found that ingestion of soy protein was associated with lower levels of total 
cholesterol, decreased LDL-cholesterol, and a decrease in triglyceride concentration 
compared to control diets (111). In an intervention study comparing the weight loss 
and lipid changes after a 12 weeks low-calorie diet consisting of either five soy-based 
meal replacements or two milk-based meal replacements and two servings of lean 
meat, the researchers reported a slightly higher weight loss in the “soy group”. The 
reduction in levels of total cholesterol, LDL-cholesterol and triglycerides were higher 
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at six weeks than 12 weeks with both diets. The group using soy-based meal 
replacements was associated with lower values of all these three lipid parameters 
after both six and 12 weeks, compared to the group who consumed milk-based meal 
replacements (112).  
Whole grain food and dietary fibre 
Whole grain products with their high content of dietary fibre are associated with a 
better health profile. An abundant intake of dietary fibre reduces the risk for 
developing several diseases; coronary heart disease, stroke, hypertension, diabetes, 
obesity and certain gastrointestinal disorders. In addition, higher intake of dietary 
fibre improves serum lipid concentrations, lowers blood pressure, improves blood 
glucose control in diabetes, aids in weight loss and appears to improve immune 
function. The dietary fibre sources are whole-grain products, vegetables, fruits, 
legumes and nuts, and products having dietary fibre as a supplement. Dietary fibre is 
classified as soluble fibre (viscous or fermentable fibres), which are fermented in the 
colon, and insoluble fibres, that to a limited extent get fermented in the colon and 
serve as bulking agents (113).  
A review of current studies demonstrated that intake of whole grain food reduced the 
risk for cardiovascular disease. The exact mechanisms remain unclear, and the effect 
may be due to the high content of cereal fibre, but also valuable nutrients found in 
whole grains, as vitamin E, magnesium, folate, vitamin B6 and phytochemicals. 
Flight et al summarises the reported effects of cereal fibre on coronary heart disease 
events as to not have an independent effect alone, but is probably best obtained from 
whole grain sources (114). 
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1.6 Energy intake and energy expenditure 
1.6.1 Dietary assessment 
Information about people’s dietary habits and food pattern can be obtained using 
several methods. The methods differ in design, structure and performance. An 
important part of the collecting procedure is that the technique chosen is not to 
intensely applied as well as comprehensive, making the subject changes his/hers 
dietary patterns and habits. Two frequently used methods are the food frequency 
questionnaire (FFQ) and dietary record (DR).  
Food frequency questionnaire (FFQ) 
This is a retrospective review of the food intake, based on the frequency of 
consumption of different food groups. Food items are organized into groups, 
according to their nutrient content. The obtained information is about the frequency 
of ingested food groups, and grouped like “eaten each day”, “twice per week”, “once 
per month” etc, giving general information about ingested nutrients, and not specific 
information for each nutrient alone. FFQ gives estimates of the usual or habitual diet 
and dietary patterns at a group level. The FFQ can be administered as a questionnaire 
which the patients will fill in themselves, or a dietician can use it as a template in a 
dietary interview.     
Dietary record (DR) 
When DR is used, the person itself document dietary intake as it occurs during the 
day, by recording the food eaten, usually in household measures like spoons and 
cups. This is done for a given time interval, usually consisting of 3 – 7 days. After the 
recorded period, the nutrient intake is calculated and then averaged, and can be 
compared to dietary references and recommendations (115). 
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1.6.2 Reporting of food intake  
When energy derived from food exceeds the energy used by the body, the net result 
will be weight gain. On the other hand, if energy expenditure (EE) exceeds energy 
intake, net weight reduction will occur. EI and EE are equal during periods of stable 
body weight. When people are asked to give information about their food habits and 
dietary pattern, they tend to misreport the actual food intake. Physical and 
psychological characteristics influence on the reporting. A relationship between 
under-reporting and increasing adiposity in subjects have been suggested. Poor body 
image and weight consciousness may also affect the inaccurate reports of EI, or the 
misreporting of energy intake can be due to dieting and dietary restraint, low social 
class and educational level (116).  
There are several methods to validate the reported food intake, like doubly labelled 
water (DLW), total water loss, resting metabolic rate and physical activity. Studies 
using the DLW technique have been revised, and in the majority of the studies a 
lower value of reported energy intake (rEI) compared to measured total energy 
expenditure (TEE) were reported. For normal-weight individuals the average 
underreporting of energy intake were 16 % less than the estimated energy 
expenditure (kcal), ranging from 0-25 %. In obese subjects the average 
underreporting values were in the 25-50 % range, averaging of 41 %. Obese persons 
generally under-reported twice as much as normal-weights. A difference between the 
genders has not been reported (117).  A study of a representative sample of 
Norwegians aged 16 – 79 with a BMI of 24.6 and 23.4 for men and women 
respectively, showed an underreporting of 38 % among men and 45 % among women 
(118).  
Reported food intakes among obese persons tend to be less than estimated total 
energy expenditure. Svendsen et al examined 50 obese persons, using a dietary 
interview based on a food-frequency questionnaire, and the participants also 
completed a recorded diary. Energy intakes were compared to energy expenditures 
measured by the doubly labelled water method. They indentified 28 subjects (12 
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males and 16 females) as under-reporters and 22 persons (11 males and 11 females) 
as non-under-reporters of energy intake by the FFQ. The same amount of under-
reporters and non-under-reporters of energy intake were estimated by using dietary 
records as well. According to the FFQ, energy intake was underreported by 14.1 % 
among all the men and by 20.6 % among all the women. Dietary records revealed an 
underreporting of 27.9 % and 31 % for men and women respectively (119).  
Misreporting of specific food items is linked to the experience of what is “good and 
bad” for health. Among under-reporters, energy derived from protein tends to be 
higher, while a lower contribution of energy from carbohydrates and fat are also 
common. The absolute intakes of these nutrients are all lower in under-reporters than 
non-under-reporters (118;120).  
1.6.3 Estimating energy expenditure 
Total energy expenditure is the total energy expended by a person during 24 hours. 
Energy costs are basal energy expenditure (BEE), active exercise and nonexercise 
activity thermogenesis, and the thermic effect of food. To estimate the total energy 
expenditure among humans, the doubly labelled water is the gold standard. However, 
it is limited in use because of its expensiveness. Another method, called indirect 
calorimetry, measures the resting metabolic rate, which is the amount of energy 
expended for the maintenance of normal body functions and homeostasis. RMR is 
10-20 % higher than the basal metabolic rate (BMR), which is the energy needed to 
maintain the metabolic activities of cells and tissues; all the physiological functions in 
the body (121). There are several predictive equations for estimating the resting 
metabolic rate in humans. The American Dietetic Association reviewed the validity 
of different predictive equations, in both non-obese and obese people. They 
concluded that the Mifflin-St Jeor equation “is more likely than the other equations 
tested to estimate RMR to within 10 % of that measured” (122). The equation for 
resting metabolic rate designed by Mifflin and St Jeor is as follow: RMR (kcal/d) = 
9.99 x weight (kg) + 6.25 x height (cm) – 4.92 x age + 166 x sex (males = 1, females 
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= 0) -161 (123). By knowing the RMR, the TEE can be estimated by multiplying the 
RMR with an activity factor. The Nordic Nutrition Recommendations (NNR) from 
2004 has different estimates of physical activity level (PAL) as indicated in table 2. 
Table 2. Estimates of physical activity levels expressed as multiplies of 
resting energy expenditure according to different levels of occupational and 
leisure activity. Adapted from Nordic Nutrition Recommendations 2004, 
page 122 (9). 
 PAL 
Bed-bound or chair-bound (not wheelchair) 1.1 – 1.2 
Seated work with no option of moving around and little or no leisure 
activity 
1.3 – 1.5 
Seated work with some requirement to move around but little leisure 
activity 
1.6 – 1.7 
Work including both standing and moving around (e.g. housework, 
shop assistant) 
1.8 – 1.9 
Very strenuous work or daily, competitive training 2.0 – 2.4 
 
Energy expenditure increases with weight or the fat free mass. Estimating of RMR by 
the equations is based on the individual’s weight, making the calculated RMR greater 
with increasing weight. Obese persons are comprehended as sedentary, but weight-
bearing activities in a large body require more energy than in a lean individual (124). 
A study from 2008 demonstrated an average PAL factor of 1.71 for healthy Danish 
men and women. PAL for the women alone were 1.68 (125). Hustvedt et al measured 
energy expenditure and physical activity using ActiReg and doubly labelled water in 
Norwegian, obese persons. Comparing the TEE, measured by DLW, with the 
measured RMR by indirect calorimetry, they discovered an average PAL among the 
obese of 1.8. These were fifty obese, non-smoking men and women with mean BMI 
34.9 and 36.6, respectively (126).  Das et al examined 30 extremely obese women 
with a BMI between 37.5 and 77 using DLW and indirect calorimetry. The subjects 
were placed into three groups based on their BMI. TEE and RMR were significantly 
greater in the highest BMI tertile compared to the lowest BMI tertile, but when 
adjusting for FFM, no significant differences were observed. There was no difference 
between the groups according to PAL, which were in average 1.63 (1,61, 1,67, 1,62) 
(127). Johannesen et al investigated the energy expenditure among ten lean and ten 
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obese women (average BMI 23 and 32.7 respectively), and discovered PAL-values of 
1.75 and 1.59, respectively. Adjusting the TEE for fat free mass, TEE was 
significantly lower among the obese women. Absolute RMR was greater in the obese 
women, but after controlling for FFM and FM the significant difference disappeared. 
Furthermore they discovered that the obese women expended almost 400 kcal less in 
activity per day than the lean individuals. The obese women spent significantly more 
time with sedentary activities and rest each day. The obese and the lean women 
reported the same intake of total kilocalories, carbohydrate, protein and fat. By 
allowing for the actual weight change during the period, both groups underreported 
their caloric intake by about 300 kcal. Seven of the ten obese and eight of the ten lean 
women underreported their intake (128).   
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2. Aims and hypothesis 
The master thesis consist of two separately parts, where part one includes analyses of 
reported food intake among morbidly obese women compared to normal weight 
control women in the MOBIL-study (Morbid Obesity treatment, Bariatric surgery 
versus Intensive Lifestyle intervention). Part two is a preliminary report of a weight 
reduction study on two different low calorie diets in morbidly obese women with 
PCOS. The main objective was to assess the effects of low-calorie-diet, and to 
compare the effects of two different low-calorie-diets, on anthropometric measures, 
body composition, lipid profile and adipokines. 
My master thesis focuses on markers for cardiovascular disease as blood lipids, body 
composition as well as adipokines, while the master thesis of Linn Mari Gunnarsrud 
Bjørnådal puts emphasis on blood glucose, insulin resistance and the hormone profile 
due to PCOS among these women. 
2.1 Part one – Analyses of reported food intake in the 
MOBIL-study 
2.1.1 Aim of the master thesis 
The objective was to explore the reported food and energy intake among morbidly 
obese women referred to a regional tertiary care centre (Morbid Obesity Centre) at 
Vestfold Hospital Trust, comparing the obtained information to the reported food and 
energy intakes among healthy lean control women. In addition, among the morbidly 
obese women the associations between reported food intake and anthropometric 
measures and blood parameters were investigated. 
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2.1.2 Hypotheses 
 Morbidly obese women have a more unfavourable lipid profile and expression 
of the adipokines, leptin and adiponectin, than healthy normal weight control 
women 
 Morbidly obese women have a different composition of their diet with regard 
to energy and macronutrient intake and choices of food items compared to 
healthy normal weight control women 
 Morbidly obese women underreport their energy intake to a larger degree than 
healthy normal weight control women 
 Morbidly obese women with a free testosterone index (FTI) score > 0.6 (pre-
PCOS) have a more unfavourable anthropometry, lipid profile, adipokine 
profile and reported food, energy and macronutrient intake than morbidly 
obese women with an FTI score ≤ 0.6 
2.2 Part two – PCOS women and effect of weight loss – 
preliminary results of the FEMIN study 
2.2.1 Aim of the master thesis 
The objective was to explore the effects of eight weeks with low-calorie-diet, and to 
compare the effects of two different low calorie diets, one based on crisp bread, the 
other based on flavoured powder solved in water, on different parameters, for 
instance weight loss and lipid profile, among obese women with PCOS recruited to 
“Kvinnehelsesenteret”, “Kvinneklinikken” at Rikshospitalet. These women were part 
of the Female Health Dietary Intervention study – the FEMIN study. However, due to 
delayed accept from the safety delegate on the inclusion of women from Aker 
University Hospital HF, only a small number (n=10) of obese women with PCOS 
were included in the study.      
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2.2.2 Hypotheses 
 Eight weeks on a low-calorie-diet leads to significant improvement in markers 
for cardiovascular disease 
o Improved body composition 
o Improved lipid profile, CRP and blood pressure 
o Improved adipokine profile (adiponectin and leptin) 
 Achieved improvements in markers for cardiovascular disease are different 
between the crisp bread diet and the powder diet of eight weeks duration 
leading to different improvement in body composition, lipid profile, CRP, 
blood pressure and adipokine profile.  
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3. Methods 
3.1 Analyses of reported food intake in the MOBIL-study 
3.1.1 Case recruitments 
Between December 2005 and May 2006, 228 morbidly obese patients (BMI ≥ 40 or ≥ 
35 kg/m2 with weight-related co morbidity) were consecutive screened at a regional 
tertiary care centre for participation in the MOBIL Study. Exclusion criteria were 
lacking of informed consents, patients in need of nursing and patients who could not 
go through an intensive lifestyle intervention due to health related reasons. A total of 
181 patients were found eligible for either bariatric surgery or intensive lifestyle 
intervention, and included in the non randomized study. The two groups were 
matched with regard of sex, age and BMI. Normal weight employees at the Vestfold 
Hospital Trust entered the study as controls after advertisement at the hospital. We 
received baseline data from 189 subjects, of which 159 were morbidly obese patients 
and 30 were normal weight controls. One-hundred-and-sixteen of the morbidly obese 
patients, and 20 of the 30 controls, were women. Baseline data from these 136 
women were used in our analysis of diet history, diet composition and underreporting 
of energy. In our study the term “obese women” is frequently used, meaning the 116 
morbidly obese women. The primary aim of the MOBIL-study was to compare the 
effects of bariatric surgery and intensive lifestyle intervention on various co 
morbidities, food intake and quality of life.  
A total of 116 obese women aged 18-65 years with a median BMI of 44; together 
with 20 normal weight controls (median BMI 23) aged 30-54 years were included in 
our study.  
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3.1.2 Data collection 
Clinical and biochemical characteristics 
All participants underwent a medical examination by a physician, and demographic 
data and medical history were recorded on standardized forms. Weight and height 
were measured in patients wearing light clothing without shoes. BMI was calculated 
as weight in kilograms divided by the square of the height in meters. Waist 
circumference was measured at the level midway between the lowest rib margin and 
the iliac crest. Hip circumference (H.C.) was measured over the widest part of the 
hip. Blood was collected by venipuncture following an overnight fast. Fasting sera 
were analysed for markers of interest; triglycerides, total cholesterol, LDL-C, HDL-
C, glucose, insulin, HbA1C, leptin, adiponectin, testosterone and SHBG. Data on 
apolipoprotein A and apolipoprotein B were not available in the MOBIL-study. 
Markers of the glucose metabolism were analysed and discussed by master thesis 
student Linn Mari Bjørnådal.  
Food frequency questionnaire 
Information about diet and dietary pattern were obtained by dietary interview based 
on an optical readable FFQ, developed by the Department of Nutrition, University of 
Oslo (for FFQ, see Appendix 1). The interviews were performed by trained clinical 
nutritionists at the regional tertiary care centre (Morbid Obesity Centre) at Vestfold 
Hospital Trust, lasting between one and two hours. The FFQ contained 
approximately 180 food items and courses. Subjects were asked to describe their diet 
during the last year, and describe how often the food items and courses were used (pr 
day, week or month) and in what quantity (units or household measures). Questions 
about food supplements, physical activity and medical history were also a part of the 
FFQ. The FFQs were scanned, optical read and controlled. Daily intakes of foods, 
energy and nutrients were computed using a computation program which has linkage 
to the Norwegian food composition table, and further analyzed in the computer 
program SPSS. 
 53
Because of low average intake of specific foods, some food items were grouped into 
the same food group. Other food items where the average intake was higher, the food 
item constitute the group itself. Following are the used food items and food groups 
based on the food item database IE96 (boldfaced words are the main groups):  
Table 3. Food items and food groups used in the analyses of reported food 
intake from the dietary interview based on the food frequency questionnaire. 
Boldfaced words are the main groups, words below are subgroups.  
 Bread  
- white bread 
- whole-grain bread 
 Egg 
 Cereal products  Milk/cream/ice cream 
- whole milk 
- partly-skimmed milk  
- skimmed milk  
- yogurt 
- ice cream 
 Cakes  Cheese 
 Potatoes,  
- fresh potatoes  
- pommes frites 
 Butter/margarine/oil 
- oil/other fat 
 Vegetables  Sugar/sweet stuff 
- chocolate  
- sweets 
 Fruits/berries  Drinks 
o Coffee 
o Tea 
o squash/soft drink (with sugar) 
- soft drink with sugar 
- squash with sugar 
o squash/soft drink (light) 
- soft drink (artificially sweetened) 
o water, mineral water 
o beer 
o wine, liquor 
 Meat/blood/entrails/pluck 
- whole meat/minced meat 
- forcemeat 
 Various 
- potato chips 
- other snacks 
- fat fruit/seeds 
 Fish/shellfish 
- fish spreads 
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Selected PAL values 
Former studies reporting physical activity levels among obese subjects have reported 
different values. Hustvedt et al measured energy expenditure and physical activity 
using ActiReg and doubly labelled water in Norwegian, obese persons. Comparing 
the TEE, measured by DLW, with the measured RMR by indirect calorimetry, they 
discovered an average PAL among the obese of 1.8. These were fifty obese, non-
smoking men and women with mean BMI 34.9 and 36.6, respectively (126). With 
regard to our obese women these persons had lower body mass indexes and they were 
equipped with ActiReg for a period of time, which might have influenced their 
activity level. On the other hand, Johannsen et al reported a PAL value of 1.59 among 
obese women (mean BMI 32.7) (128). Furthermore, Das et al, who examined women 
with a BMI between 37.5 and 77 using DLW and indirect calorimetry, found an 
average PAL value for the whole group to be 1.63. They also split the women into 
BMI tertiles, and women with BMI between 37.5 – 45 (mean 40.8) had PAL 1.61, 
while women with BMI between 45.1 – 52 (mean 49.47) and BMI between 52.1 – 77 
(mean 60.3) had PAL values of 1.67 and 1.62 respectively (127). According to this, 
we decided to use a PAL value of 1.6 when estimating the total energy expenditure 
among our obese women. The PAL value selected to the healthy lean controls was 
1.8, according to NNR and based on the information about their work (9). This level 
is higher than demonstrated in a Danish healthy population (125), but we assumed 
that our control women were more physical active due to their work and health 
occupation, as they are health workers.  
Definition of under-reporters and non-under-reporters of energy 
Subjects were identified as under-reporters or non-under-reporters based on 
calculation of the reported energy intake (rEI) and the estimated total energy 
expenditure (eTEE):  
rEI - eTEE = < 0 ≥   
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According to this calculation, subjects who reported an intake that was less than the 
estimated TEE were classified as under-reporters. Subjects defined as non-under-
reporters had a reported energy intake higher than the estimated TEE.  
Definition of pre-PCOS women 
We were interested in studying if there was a difference in anthropometry, lipid and 
adipokine profile, diet composition and underreporting of energy between the obese 
women with PCOS versus the obese women without PCOS. In lack of PCOS 
diagnosis in the MOBIL-study, a surrogate marker for PCOS was chosen; free 
testosterone index score. FTI was calculated by using measured serum total 
testosterone and SHBG, parameters which indicates hyperandrogenemia. The 
reference value for FTI among women is 0.1 – 0.6. Women with PCOS have FTI 
scores around 1 (65;66). Since the reference value is up to 0.6, a FTI score above 0.6 
may indicate the beginning of a PCOS diagnosis. We therefore decided to classify 
women with FTI > 0.6 as pre-PCOS subjects. 
3.1.3 Statistical methods 
The computing program SPSS for windows (version 16.0) was used to perform the 
statistical analysis in the study. The data were evaluated in regard to normal 
distribution by means of Shapiro-Wilk test of normality, histograms and Q-Q plots. 
The principal data were non-normally distributed, and the control group of women 
was small. Therefore, non-parametric tests were used. The results are presented as 
medians, point estimates and 95 % confidence intervals (CI) for the point estimates. 
Median differences were tested with the non-parametric test Mann-Whitney U test. 
The results were considered significant at p< 0.05. After consultation with the 
statistician Petter Laake, we agreed that p-values between 0.05 and 0.1 were 
interpreted as a tendency toward significance. Furthermore, after advice from Petter 
Laake, normally distributed data which almost reached significant differences 
between the groups were further investigated with a parametric test, independent-
samples t-test. Statistically significant correlation between different variables was 
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calculated with the non-parametric Spearman rank order correlation (rho). Significant 
correlation was considered at p< 0.05, and the significant correlations are expressed 
as rho-values. 
3.2 PCOS women and effect of weight loss – preliminary 
results of the FEMIN study  
3.2.1 Case recruitments 
Women attending “Kvinnehelsesenteret”, “Kvinneklinikken” at Rikshospitalet 
University Hospital HF in Oslo diagnosed with PCOS, aged 19 to 38 years, having a 
BMI > 35 kg/m2 were invited to participate in the FEMIN study (information letter 
given to the women, see Appendix 2). Obese females with possible PCOS diagnosis 
coming to Aker University Hospital HF were also asked if they wanted to participate 
in the study. If interested, they were sent to Rikshospitalet to get the PCOS diagnosis 
confirmed by ultrasound. Subjects were excluded if they had a BMI < 35 kg/m2, were 
pregnant or breastfeeding, had other medical conditions as Cushing’s syndrome and 
androgen producing cysts/ tumours, used oral or parenteral contraceptives, used 
medicaments to improve insulin sensitivity (metformin) or had anovulation due to 
hyperprolactinemia. Participants had to quit using oral contraceptive or other 
hormone treatment four weeks or two weeks respectively, before the study start. The 
women who agreed to participate were block randomized, in blocks of six. Three 
were placed in the powder diet group, and the last three to the crisp bread diet group. 
The time of randomization was at the same time as the women were summoned to 
Rikshospitalet for the first meeting (second information letter sent to the women 
together with the summons, see Appendix 3).  
A total of ten women aged 19-37 years, were included in our study. Five women were 
randomized to the crisp bread diet, while the other five women were randomized to 
the powder diet. Due to heavily problems drinking the powder shakes, one woman 
dropped out from the powder diet after few days on the diet. She had great desire to 
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accomplish an eight weeks diet, and she asked to be transferred to the crisp bread 
diet. According to the protocol she was no longer part of the FEMIN study, but due to 
our small selection of women, we decided to let her continue on the crisp bread diet 
in our study. Furthermore, one of the women in the crisp bread diet group did not 
attend the second visit, then becoming a “drop out”. Therefore, we had nine 
participating women in our study, five on the crisp bread diet and four women in the 
powder diet group.  
3.2.2 Data collection – visit 1 
Anthropometry, blood pressure and blood samples  
The women’s standing body height (cm) were measured to nearest cm. Body weight 
(kg) was assessed using a computerized Bioelectrical impedance analysis (BIA) 
(Tanita BC-418MA), and was measured to the nearest 0.1 kg. The subjects were 
barefoot and lightly clothed, and one kilogram was subtracted for the clothes. Body 
composition as fat free body mass, total fat mass and percent body water were 
estimated by the BIA. Waist circumference was measured between the lowest rib and 
the iliac crest using a non-elastic tape measure. Hip circumference was measured over 
the widest part of the hip. A newly accepted marker for insulin resistance/central 
obesity is the neck circumference, which was also measured at the same time (129). 
We calculated body mass index as a measure for overall body composition and waist-
to-hip-ratio as measure of abdominal fat distribution. The blood pressure was 
measured by an automated device, while the subjects were in a seated position. Blood 
samples were collected from all patients by trained nurses between 0800 and 1100 
hours, after an overnight fast. They were centrifuged immediately and stored at - 80 
ºC until assayed. Anthropometric measures and blood pressure were performed by a 
clinical nutritionist, Line Kristin Johnson, or by the two master thesis students, Linn 
Mari Bjørnådal and Hanne Lessner, following standardized procedures. Data 
collection was done at baseline and after 8 weeks with one of the diets. Fasting sera 
were analyzed for markers of interest; triglycerides, total cholesterol, LDL-C, HDL-
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C, apolipoprotein A, apolipoprotein B, glucose, insulin, c-peptide, HbA1C, Hs CRP, 
leptin, adiponectin, SHBG, LH and FSH. Markers for the glucose metabolism and 
PCOS status were analysed and discussed in the master thesis by Linn Mari 
Bjørnådal.   
Questionnaires and hirsutisme score 
During visit one, at baseline, the obese women were asked to fill in four 
questionnaires; a food frequency questionnaire (the same as was used in the MOBIL-
study, see Appendix 1), a questionnaire about life quality and PCOS, the 
gastrointestinal symptom rating scale (GSRS) and a questionnaire about personally 
experienced health/life quality (SF 36). Hirsutism was classified according to the 
Ferriman-Gallwey score(130). Data obtained from these questionnaires and from the 
Ferriman-Gallwey score were not a part of my master thesis, and therefore the results 
are not referred to in my master thesis. However, data on hirsutism score and the 
GSRS are described in the master thesis by Linn Mari Bjørnådal.  
3.2.3 Weight reduction period 
The included PCOS women were randomized to either of the low-calorie diets; the 
“crisp bread diet” or the “powder diet” (meal replacement shakes). Both diets 
consisted of less than 1000 kcal per day. The participants got thorough information 
about the diet they were randomized to, and they received enough crisp breads or 
meal replacement shakes for eight weeks duration. The PCOS women started as soon 
as possible on the intensive weight reduction period lasting for eight weeks. During 
the weight loss phase, the clinical nutritionist, Line Kristin Johnson, or the master 
thesis students called the women once a week, to give them moral support, as well as 
the participants were given the opportunity to ask questions and reel off their 
frustrations.  
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The crisp bread diet                   
The crisp bread diet was based on easily accessible Norwegian food items, dispersed 
on four meals, where crisp bread was used in three of these four meals. Crisp bread 
from Wasa, Ideal Wasa A/S, was used, mainly “Wasa Husman”, “Wasa Fibre Plus” 
and “Wasa Sport”. These crisp breads are made of whole grain rye, and have a high 
content of dietary fibre. During the day, the women were supposed to eat six crisp 
breads dispersed on breakfast, lunch and supper, and they had to select from three 
groups of different spreads. One crisp bread should have a spread of fatty fish, 
another with a sparingly amount of cottage cheese or another low-fat (3%) cheese. 
The spreads for the last four crisp breads were lean meat (e.g. ham, turkey, lean liver 
pate) or fish (e.g. crabsticks, fish pudding). One glass of skimmed milk was included 
in each of these meals. The dinner was composed of a certain amount of lean meat, 
fish or poultry, or fatty fish, and a small amount of potato, rice or pasta. In addition 
there were no restrictions on the intake of vegetables (raw or boiled). Furthermore, 
one fruit per day was allowed, and the participants were recommended to take a 
multivitamin pill daily, and use one teaspoon soy margarine during cooking. The 
women were encouraged to drink a lot of water and other drinks without calories. See 
Appendix 4 for the nutrient composition of the crisp bread diet, and Appendix 5 for 
further description of the diet.  
 
The powder diet - meal replacement shakes             
Flavoured powders from Nutrilett, Axellus AS, were utilized by the women who used 
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this diet. The shakes were solved in water to generate shakes with either chocolate or 
strawberry flavour. Each day, the women had to drink eight such shakes supplying a 
total of 888 kcal. The flavoured powders contained mainly soy protein, fructose and 
soy fibres, and as well vitamins and minerals. Five of these shakes (providing 555 
kcal) would provide enough of the essential nutrients that the body need per day. In 
addition to the shakes, the women were allowed to eat a few vegetables low in dietary 
fibre, like different types of salad, cucumber, tomato, onion, garlic, paprika and 
mushrooms, and also 150 grams of root vegetables (carrots, turnip cabbage, broccoli 
etc.) and one fruit per day. The women were encouraged to drink a lot of water and 
other drinks without calories. See Appendix 4 for nutrient content of the powder diet, 
and Appendix 6 for the description of the diet.  
3.2.4 Data collection – visit 2 
After eight weeks, the participating women were summoned to visit number two. The 
same procedure regarding anthropometric measures, blood samples and blood 
pressure were used, as described earlier. During the second visit they completed three 
of the same questionnaires they filled in at visit 1 (not the FFQ). At the end of the 
visit they got instructions to increase the calorie content of their diets to 1300 kcal, 
and they received a pedometer as reward for completing the eight weeks of diet. 
3.2.5 Statistical methods 
The computing program SPSS for windows (version 16.0) was used to perform the 
statistical analysis in the study. The data were evaluated in regard to normal 
distribution by means of Shapiro-Wilk test of normality, histograms and Q-Q plots. 
The achieved differences ((Δ), baseline data – eight weeks data) in different 
parameters after the low-calorie-diet (both together) at eight weeks from baseline 
were normally distributed. Therefore a parametric test were used; one-sample t-test, 
to assess whether these differences (Δ) were significant from baseline. Furthermore, 
to assess possible differences between the two diet groups with regard to the achieved 
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changes (Δ) in the different parameters within each group, we used independent-
samples t-test after advice from the statistician Petter Laake. The results are presented 
as means ± standard deviations (SD), achieved mean differences (Δ) and 95 % 
confidence intervals for the mean differences. The results were considered significant 
at p< 0.05. After advice from Petter Laake, p-values between 0.05 and 0.1 were 
interpreted as a tendency toward significance. Statistically significant correlation 
between different variables was calculated with the non-parametric Spearman rank 
order correlation (rho). Significant correlation was considered at p< 0.05, and the 
significant correlations are expressed as rho-values. Comparison of baseline 
characteristics and also after eight weeks measurements, were done by a non-
parametric test, due to a small number of women in each diet group and thereby 
impossibility to predict the distribution of the data. Median differences were tested 
with the non-parametric test Mann-Whitney U test.  
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4. Results 
4.1 Analyses of reported food intake in the MOBIL-study 
4.1.1 Characterization of the morbidly obese women and the 
normal weight control women 
Anthropometric measures 
A characterization, by anthropometric measures, of the 116 morbidly obese women 
and the 20 healthy normal weight controls who participated in the present study is 
summarized in table 4. As expected, all anthropometric measures (except height) 
were significantly higher among obese women than among the lean control women.  
Table 4. Anthropometric measures of the morbidly obese women and the 
normal weight control women (median values, point estimates for difference 
with 95 % confidence interval are given when significant difference between 
the groups were observed) * 
ANTHROPOMETRY 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Age (y) 42.0 44.1  - -  0.825 
Weight (kg) 120.0 64.9 57.5 (51.0 ; 65.0) < 0.001 
Height (cm) 167.0 167.5 -   - 0.863 
Body Mass Index (kg/m²)  43.9 22.9 21.0 (19.0 ; 23.0) <0.001 
Waist circumference (cm) 128.0 77.0 52.0 (47.0 ; 58.0) <0.001 
Hip circumference (cm) 137.0 98.0 38.0 (34.0 ; 43.0) <0.001 
Waist-to-hip ratio 0.95 0.76 0.17 (0.13 ; 0.20) <0.001 
* Differences between the obese and control women were tested with the Mann-Whitney U 
test.   
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Lipid profile 
Characteristics of the obese women and the control subjects according to their lipid 
profile are shown in table 5. Analyses of the blood samples demonstrated that there 
were statistically significant differences in the median concentrations of total 
cholesterol, LDL-C, HDL-C and triglycerides between the obese women and the lean 
control women.  
Table 5. Lipid profile of the morbidly obese women and the normal weight 
control women (median values and point estimates for difference with 95 % 
confidence interval) * 
LIPID PROFILE 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Total cholesterol (mmol/L) 5.2 4.4 0.7 (0.1 ; 1.1) 0.014 
LDL-cholesterol  (mmol/L) 3.2 2.4 0.8 (0.4 ; 1.1) <0.001 
HDL-cholesterol (mmol/L) 1.2 1.8 -0.5 (-0.7 ; -0.4) <0.001 
Triglycerides (mmol/L) 1.5 0.6 0.8 (0.6 ; 1.1) <0.001 
* Differences between the obese and control women were tested with the Mann-Whitney U 
test 
The relationships between the anthropometric measures and the lipid profile were 
investigated using Spearman rank order correlation (rho). For both groups, the total 
cholesterol level was correlated to age. Among the obese, triglyceride level were 
correlated to age, waist circumference and the waist-to-hip ratio. In the control 
women, total cholesterol level and the concentrations of LDL-C and HDL-C were 
correlated to the waist circumference. The LDL-C and HDL-C levels were also 
correlated to the waist-to-hip ratio. Furthermore, the HDL-C concentration correlated 
to age, while the triglyceride level was negatively correlated to height (table 6 & 7).  
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Table 6. The relationships between the lipid profile and anthropometric 
measurements among the obese women (Spearman’s correlation coefficient 
rho). Negative rho indicates negative correlation. Only significant 
correlations are stated. 
OBESE WOMEN (n=116) Age 
 
 
 
Weight Height 
 
 
 
BMI W. C. H. C. WHR 
Total cholesterol  0.27** - - - - - - 
LDL-cholesterol   - - - - - - - 
HDL-cholesterol  - - - - - - - 
Triglycerides  0.18* - - - 0.21* - 0.24* 
BMI = body mass index. W.C. = waist circumference. H.C. = hip circumference. WHR = 
waist-to-hip ratio. 
* Correlation was significant at the 0.05 level.    
** Correlation was significant at the 0.01 level 
 - = not significant correlation 
 
Table 7. The relationships between the lipid profile and anthropometric 
measurements among the normal weight control women (Spearman’s 
correlation coefficient rho). Negative rho indicates negative correlation. 
Only significant correlations are stated. 
CONTROL WOMEN (n=20) Age 
 
 
 
Weight Height 
 
 
 
BMI W. C. H. C. WHR 
Total cholesterol  0.52* - - - 0.54* - - 
LDL-cholesterol   - - - - 0.55* - 0.50* 
HDL-cholesterol  0.51* - - - 0.45* - 0.49* 
Triglycerides  - - -0.46* - - - - 
BMI = body mass index. W.C. = waist circumference. H.C. = hip circumference. WHR = 
waist-to-hip ratio 
* Correlation was significant at the 0.05 level. 
** Correlation was significant at the 0.01 level. 
 - = not significant correlation 
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4.1.2 Adipokines 
The levels of the adipokines leptin and adiponectin were investigated, and the obese 
women had significantly elevated concentrations of leptin and lower levels of 
adiponectin compared to the healthy, lean control women (table 8). 
Table 8. The adipokine profile of the morbidly obese women and the normal 
weight control women (median values and point estimates for difference 
with 95 % confidence interval) * 
ADIPOKINE PROFILE 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Leptin (ng/ml) 60.1 14.9 46.1 (39.5 ; 53.1 ) <0.001 
Adiponectin (ng/ml) 5452 8017 -2488 (-4246 ;  -937) 0.002 
* Differences between the obese and control women were tested with the Mann-Whitney U 
test. 
Furthermore, we investigated the correlation between the adipokines and different 
anthropometric parameters and lipid values using Spearman rank order correlation 
(rho). Among the obese, leptin was positively correlated to weight, BMI and waist- 
and hip circumference. With regard to the levels of adiponectin, which was 
significantly lower among the obese women, adiponectin was negatively correlated to 
weight, BMI and waist circumference among the obese subjects, while the levels of 
HDL-C were positively correlated with adiponectin (table 9). Among the control 
women, significant positive correlation (p<0.05) between the level of leptin and waist 
circumference (rho = 0.51), LDL-C concentration (rho = 0.51) and triglyceride level 
(rho = 0.24) were observed.  
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Table 9. The relationships between the adipokines and anthropometric 
measurements and among the obese women (Spearman’s correlation 
coefficient rho). Negative rho indicates negative correlation. Only 
significant correlations are stated 
OBESE WOMEN (n=116) Age 
 
 
 
Weight Height 
 
 
 
BMI W. C. H. C. HDL-C 
Leptin - 0.44** - 0.48** 0.33** 0.48** - 
Adiponectin - -0.26* - -0.22* -0.27**  - 0.24* 
BMI = body mass index. W.C. = waist circumference. H.C. = hip circumference. WHR = 
waist-to-hip ratio 
* Correlation was significant at the 0.05 level. 
** Correlation was significant at the 0.01 level.  
- = not significant correlation 
4.1.3 Energy intake and macro nutrients  
The two groups were compared in order to explore differences in the reported energy 
intake and/or the macro nutrient composition (table 10). The obese women had a 
median intake of energy of 2603 kcal, while the control women had 2301 kcal as the 
median. This difference in 300 kcal was not statistically significant. The reported 
intake of protein, carbohydrate, sugar and fibre separately were not significant 
different between the two groups. The fat intake tended to be higher among the obese 
women compared to the control subjects (p-value 0.087). When analyzing for 
differences in the intake of the different types of fat, we observed a trend among the 
obese women to have a higher intake of saturated fat compared to the control women 
(p-value 0.077). Ingestion of monounsaturated fat and polyunsaturated fat were not 
significantly different between the groups. Finally, the data showed that the control 
women drank significantly more alcohol than the obese women (p-value <0.001).  
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Table 10. Intake of macronutrients among the morbidly obese women and 
the normal weight control women (median values, point estimates for 
difference with 95 % confidence interval are given when significant 
difference between the groups were observed) * 
MACRONUTRIENTS 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Energy intake (kcal) 2603 2301 - - 0.124 
Protein intake (g) 105 103 - - 0.527 
Fat intake (g) 111 91 16.2 (-2.5 ; 34.5) 0.087** 
   -saturated fat (g) 43 36 6.6 (-1.0 ; 15.2) 0.077** 
   -monounsaturated fat (g) 37 31 - - 0.131 
   -polyunsaturated fat (g) 20 18 - - 0.176 
Cholesterol (mg) 327 285 - - 0.424 
Carbohydrate intake (g) 287 254 - - 0.107 
   -sugar intake (g) 40 34 - - 0.839 
Dietary fibre intake (g) 26 27 - - 0.619 
Alcohol consumption (g) 1 4 -2.6 (-3.9 ; -1.8) <0.001 
* Differences between the obese and control women were tested with the Mann-Whitney U 
test. 
** The difference tended to be significantly different (0.05 < p > 0.1) 
In Norway we have nationwide dietary assessments; the latest updated information 
about the diet among men and women was published in 1999 (data from 1997) (8). 
We wanted to compare the diet composition among our participating women 
compared to the Norkost Survey women, who represent a nationwide selection of 
women aged 16-79 years. The obese women in the MOBIL-study and the control 
women had approximately the same contribution of energy from the different 
macronutrients. Compared to the Norkost Survey women, our women, both the lean 
and the obese, had more of the total energy from fat and less from carbohydrate. The 
Norkost Survey women and our control women had the same energy contribution 
from alcohol; a minor energy percentage from alcohol was seen among the obese 
women. Furthermore, we compared the diet composition to our participating women 
to the Nordic Nutrition Recommendations (9). With regard to the NNR, both the 
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obese and the control subjects had slightly elevated energy percentages from fat and 
saturated fat compared to the recommendations. Due to the enhanced contribution of 
energy from fat, the energy percentages from carbohydrate were lower than 
recommended for both groups (table 11). 
Table 11. Intake of macronutrients as  percentages of total energy intake 
(E%) among the morbidly obese women, the normal weight control women 
and the Norkost Survey women, together with the recommendations for E % 
from macronutrients for adults and children from 2 years of age.  
ENERGY PERCENTAGES 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Norkost  
women  
(n=1374)  * NNR ** 
Energy percent from     
Protein (%) 16.6 17.5 16.2 10-20 
Fat (%) 36.7 36.1 30.4 25-35 
   -saturated fat (%) 14.6 14.9 12.2 < 10 
   -monounsaturated fat (%) 12.2 12.0 10.7 10-15 
   -polyunsaturated fat (%) 7.1 6.4 5.2 5-10 
Carbohydrate (%) 45.0 45.1 52.1 50-60 
   -sugar (%) 6.0 6.2 9.1 < 10 
Alcohol consumption (%) 0.2 ‡ 1.3 ‡  1.4 - 
Energy percentages from the different macronutrients were not significantly different 
between the obese women and the control women in our study, except from E % from 
alcohol (‡), which was significantly higher among the control women. 
* data from the Norkost Study (8) 
**Recommendations from the Nordic Nutrition Recommendations 2004 (9). 
4.1.4 Intake of food items  
Table 12 summarizes the median intake of food items, reported by the obese women 
and the control subjects. Total intake of food was greater among the obese than the 
control women. The obese women reported a higher intake of meat and especially 
processed meat, like sausages and meat loafs. Statistically significant variations in the 
use of butter, margarine and oils were also observed between the groups, the obese 
women using a greater proportion of these food items. The drinking pattern was 
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different in the two groups. The obese women seemed to report overall more drinks 
than the control women, especially were the consumption of light squash as well as 
artificially sweetened soft drinks greater among the obese. On the other hand, the 
control group reported a higher intake of alcoholic beverages. 
Table 12. Reported daily intake of food (g/day) in morbidly obese women 
and normal weight control women according to dietary interviews based on 
a FFQ (median values, point estimates for difference with 95 % confidence 
interval are given where statistically significant differences were observed) 
* 
FOOD ITEMS (gram/day) 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Total intake 3632 3045 561.6 (81.1 ; 1074.4) 0.022 
Bread 186 172 -  -  0.452 
White bread†  -  - -   -  
Whole-grain bread 80 140 - -  0.433 
Cereal products 58 61  - -  0.634 
Cakes 23 21  - -  0.980 
Potato 64 61  - -  0.768 
Fresh potatoes  51 50  - -  0.768 
Pommes frites 5 6  - -  0.725 
Vegetables 247 281  - -  0.419 
Fruits, berries 189 195  - -  0.610 
Meat, blood, entrails/pluck 171 120 45.7 (10.3 ; 77.3) 0.01 
Whole meat, minced meat 65 57  - -  0.951 
Forcemeat 76 48 29.1 (8.0 ; 53.1) 0.007 
Fish, shellfish 54 64  - -  0.246 
Fish spreads 9 4  - -  0.512 
Egg 16 16  - -  0.412 
Milk, cream, ice cream 294 246  - -  0.946 
Whole milk 0 0  - -  0.265 
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FOOD ITEMS (gram/day) 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Partly-skimmed milk 27 16  - -  0.687 
Skimmed milk 0  0 -  -  0.639 
Yogurt 15 25  - -  0.520 
Ice cream 7 7  -  - 0.643 
Cheese 39 46  -  - 0.640 
Butter, margarine, oil 45 26 18.4 (5.4 ; 30.8) 0,003 
Oil, other fat 1 1  -  - 0.276 
Sugar, sweet stuff 27 20  -  - 0.665 
Chocolate 13 10 -   - 0.824 
Sweets 4 6 -  -  0.880 
Drinks 1713 1483 312.5 (-14.0 ; 668.1) 0.058** 
Coffee 240 420  -  - 0.356 
Tea 0  0  - -  0.336 
Squash, soft drink, with sugar 0 5  - -  0.211 
Soft drink with sugar 0 3  - -  0.103 
Squash with sugar 0 0  -  - 0.165 
Squash, soft drink, light 250 0 210.0 (90.0 ; 465.0) <0.001 
Soft drink, artificially 
sweetened  180 0 180 (70.0 ; 465.0) <0.001 
Water, mineral water  649 488  - -  0.770 
Beer 4 51 -35.0 (-53.0 ; -14.0) <0.001 
Wine, liquor 3 29 -19.5 (-28.0 ; -12.0) <0.001 
Various 162 125  -  - 0.400 
Potato chips 4 2  -  - 0.321 
Other snacks 0 (8 ‡) 0 (0.9‡)  0 (0.0 ; 1.0) 0.095 ** 
Fatty fruit, seeds 1 5 -3.0 (-5.0 ; -1.0) 0.007 
* Differences in reported intake of food among the obese and control women were tested 
with the Mann-Whitney U test. 
** The difference tended to be significantly different 
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† data on reported intake was not available 
‡ mean intake  
4.1.5 Intake of fat and saturated fat and choice of food 
Since the consumption of fat among the obese women tended to be higher than 
among the control subjects, we wanted to investigate the relationships between fat 
intake and different food items, using Spearman rank order correlation (rho). 
Ingestion of fat was positively correlated (p<0.05) to the intake of these food items 
among the obese women: bread, white bread, cereals, cakes, potatoes, meat, minced 
meat, forcemeat, fish, partly skimmed milk, ice cream, cheese, butter, margarine and 
oil, sugar and sweet stuff, chocolate, sweets, light squash and soft drink and 
artificially sweetened soft drinks, potato chips, snacks and fatty fruits. Ingestion of 
saturated fat was positively correlated (p<0.05) to the same food items as total fat 
intake, except from fish. In addition, intake of saturated fat was positively correlated 
with squash and soft drinks with sugar, in the obesity group.  
In the normal weight group, the fat intake was positively correlated (p<0.05) to the 
intake of fewer food items; bread, whole grain bread, meat, mince meat, sugar, sweet 
stuff, sweets, and was negatively correlated with the consumption of tea. Ingestion of 
saturated fat was positively correlated (p<0.05) to the intake of cakes, pommes frites, 
meat, sugar, sweet stuff and sweets in the control group (for correlation coefficients, 
see Appendix 7). 
The higher number of positive correlations between the intake of total fat and 
saturated fat and different food items among the obese women compared to the lean 
control subjects may suggest that the obese women ate more fat containing food 
items whereas the fat intakes among the control subjects were restricted to fewer, 
particularly fatty food items.   
4.1.6 Plasma cholesterol level and food items  
In the group of obese women, statistically significant (p<0.05) negative correlations 
were found between the plasma level of total cholesterol and intake of cereals and 
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oils, and between the level of LDL-cholesterol and the intake of alcohol, cereals and 
snacks (not potato chips).  
Among the controls the level of total cholesterol and LDL-C were correlated 
positively (p=0.019) to the intake of potato chips. Plasma level of HDL-C was 
negatively correlated (p=0.044) to reported intake of cheese. The levels of 
triglycerides and the reported intakes of pommes frites, ice cream and cheese 
correlated positively (p<0.05); while the intakes of butter, margarine and drinks and 
water gave negative correlation (p<0.05) with the triglyceride levels (for correlation 
coefficients, see Appendix 8). 
4.1.7 Adipokines and food items 
We investigated the statistically significant correlation (p < 0.05) between levels of 
leptin and adiponectin with the reported intake of different food items (table 13 & 
14). In the obese group, the concentration of leptin had a positive relationship to the 
intake of cereals (p=0.004) and ice cream (p=0.029), while the reported intake of 
alcohol (wine and liquor) (p=0.008), fish (p=0.033) and water (p=0.007) correlated 
negatively with the levels of leptin. In the control women, a positive relationship 
between levels of leptin and the reported intake of partly skimmed milk, wine and 
liquor was shown, while the intake of bread was negatively correlated with leptin 
levels (all p-values < 0.05).  
Among the obese, reported intake of water (p<0.01) and vegetables (p=0.022) was 
positively related to the levels of adiponectin. Another finding was that among the 
obese women the levels of adiponectin were correlated negatively to the intake of 
light squash and artificially sweetened soft drinks (p-values < 0.01) whereas in the 
control subjects, a negative correlation between levels of adiponectin and the reported 
intake of sugar containing squash and soft drinks (p=0.047) was found.     
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Table 13. The relationships between the adipokines, leptin and adiponectin, 
and the reported intake of different food items among the obese women 
(Spearman’s correlation coefficient rho). Negative rho indicates negative 
correlation. Only significant correlations are stated. 
OBESE WOMEN (n=116) Alcohol Cereals Vegetables Fish Ice cream 
Leptin -0.27** 0.26** - -0.20* 0.23* 
Adiponectin - - 0.21* - - 
OBESE WOMEN (n=116) 
Light squash/ 
soft drinks 
Artificially 
sweetened 
soft drinks Water Wine/beer  
Leptin - - -0.25** -0.25  
Adiponectin -0.28** -0.26** 0.34** -  
* Correlation was significant at the 0.05 level  
** Correlation was significant at the 0.01 level 
 - = not significant correlation  
. 
Table 14. The relationships between the adipokines, leptin and adiponectin, 
and the reported intake of different food items among the normal weight 
control women (Spearman’s correlation coefficient rho). Negative rho 
indicates negative correlation. Only significant correlations are stated. 
* Correlation was significant at the 0.05 level  
** Correlation was significant at the 0.01 level 
- = not significant correlation 
CONTROL WOMEN (n=20) Bread 
Partly 
skimmed milk
Squash/soft 
drinks with 
sugar Fatty fruit Wine/beer 
Leptin -0.48* 0.45* - - 0.49* 
Adiponectin - - -0.45* -0.59** - 
4.1.8 Accuracy of reported energy intake 
The estimated total energy expenditure is predicted by resting metabolic rate 
multiplied by an activity factor. Since the physical activity level differ between 
subjects, and between obese and lean women, we decided to calculate the TEE based 
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on two different PAL values for the obese women and the control subjects. 
According to the Nordic Nutrition Recommendations (9) and previous literature 
(127;128), we choose a PAL factor of 1.6 among the obese subjects and 1.8 among 
the control women.     
PAL 1,6  in obese women and PAL 1,8 among the controls 
Using a PAL value of 1.6 to estimate the TEE among the obese women yielded an 
energy expenditure of 2981 kcal (median) per day. Calculating the TEE for the 
control women with a PAL value of 1.8 gave an energy expenditure of 2362 kcal, 
which is significantly lower than in the obesity group. Extracting the estimated TEE 
from the reported energy intake demonstrated a median under-reporting of about 570 
kcal (17.4 %) per day for the obese women, while the energy intake matched the 
energy expenditure among the control subjects (median) (table 15). 
Table 15. Accuracy of reported food intake among the morbidly obese 
women and the normal weight control women (median, point estimate for 
difference with 95 % confidence interval are given where statistically 
significant differences were observed) * 
ACCURACY OF 
REPORTED ENERGY 
INTAKE 
Obese 
women 
(n=116) 
Control 
women 
(n=20) 
Point estimate 
for difference 95 % CI p-value * 
Reported EI (kcal) 2603 2301 - - 0.124 
RMR (kcal) 1863 1312 571.0 (493.4 ; 661.3) < 0.001 
PAL  1.6 1.8 - - - 
eTEE (kcal) 2981 2362 653.4 (530.8 ; 797.9) < 0.001 
EI - eTEE (kcal) -570 5 -456.9 (-856.4 ; -16.8) 0.044 
EI - eTEE (%) -17.4 0.3 -13.6 (-28.4 ;-0.4) 0.047 
* Differences in reported intake of food among the obese and control women were tested 
with the Mann-Whitney U test.                 
EI = energy intake. RMR = resting metabolic rate. PAL = physical activity level. eTEE = 
estimated total energy expenditure.  
Splitting the group of obese women into under-reporters (rEI – eTEE < 0) and non-
under-reporters (rEI – eTEE ≥ 0), 70 % (n=81) of the obese women underreported 
their energy intake. In the control group, 10 (50%) of the lean women underreported 
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their energy intake (table 16). The obese under-reporters underreported 
approximately 848 kcal per day, which constituted 25.3 % of the total estimated 
energy requirement. The controls underreported in median 17.6 % (median 428 kcal), 
and this was significantly lesser than among the obese women. On the other hand, the 
obese women who did not underreport had a median over-report of 624 kcal, 18.7 % 
more than the estimated requirement. Among the non-underreporting control women; 
479 kcal, constituting 20.3 %, was the extra intake reported by these women 
compared to the estimated total energy requirement.  
Table 16. Number of under-reporters and non-under-reporters among the 
morbidly obese women and the normal weight control women. Amount of 
misreported energy intake compared to the estimated total energy 
expenditure (rEI-eTEE) are given in absolute values and percentages 
(median) *  
Obese women (n=116) 
 
Control women (n=20) 
 
UNDER-REPORTERS VERSUS 
NON-UNDER-REPORTERS 
 
 
Under-
reporters 
Non-under-
reporters 
Under-
reporters 
Non-under-
reporters 
Number (n) 81 35 10 10 
Number (%) 69.8 30.2 50.0 50.0 
Misreported value (kcal)  -848** 624‡ -428** 479‡ 
Misreported value (%) -25.3 18.7 -17.6 20.3 
* Differences between under-reporters and between the non-under-reporters were tested with the 
Mann-Whitney U test.   
** Significant difference (p=0.037) was seen between the two groups using Mann-Whitney U test 
‡ The difference in misreported value tended to be different between the two groups (p=0.078) 
To illustrate the misreporting of energy intake compared to the estimated energy 
expenditure, we designed a histogram (see figure 8 and 9). The number of subjects 
who misreported the energy intake is illustrated by the bars. Each bar represents 200 
kcal. The zero on the x-axis represents correct reporting of energy intake; the 
reported energy intake is equal to the estimated energy expenditure. The bars to the 
left of zero represent underreporting, while the bars to the right represent over 
reporting. 
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Figure 8.Estimated TEE from a PAL value of 1.6 among obese women. The mis-
report of energy intake was expressed by the reported intake minus the TEE. The 
bars indicate number of subjects who misreported within that 200 kilocalorie 
range. The bars to the left of “0” (EI-TEE = 0 = energy balance) represent the 
number of subjects who underreported their energy intake, while the bars to the 
right of “0” represent over reporting. The histogram is slightly shifted to the left, 
indicating a higher proportion of under-reporters. 
 
Figure 9.Estimated TEE from a PAL value of 1.8 among control women. The mis-
report of energy intake was expressed by the reported intake minus the TEE.  The 
bars indicate number of subjects who misreported within that 200 kilocalorie 
range. The bars to the left of “0” (EI-TEE = 0 = energy balance) represent the 
number of subjects who underreported their energy intake, while the bars to the 
right of “0” represent over reporting.    
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We found a significant inverse correlation between BMI and the amount of 
misreporting in the obese women (rho= -0.23, p= 0.015). With increasing BMI, the 
amount of underreported kilocalories enhanced (figure 10). 
 
Figure 10. The significant (p=0.015) inverse correlation between BMI and 
the mismatch in reported kilocalories compared to estimated energy 
expenditure (rho=-0.23) among the obese women (n=116) is illustrated. By 
removing the two most outliers the correlation was further enhanced to -
0.26 (p<0.01). 
4.2 Women with FTI ≤ 0,6 versus women with pre-PCOS 
We were interested in studying if there was a difference in anthropometric 
measurements, lipid and adipokine profile and dietary intake between the obese 
women with pre-PCOS versus the obese women without PCOS. In lack of PCOS 
diagnosis a surrogate marker for PCOS (free testosterone index score) was chosen. 
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We therefore divided the 116 obese women into two groups. The women having an 
FTI score below or equal to 0.6 were compared to women with an FTI score above 
0.6 (pre PCOS). There were 68 women in the first group and 46 in the latter. Two 
women were excluded because information on testosterone level or SHBG was 
lacking. Forty-six out of 116 women had pre-PCOS status, constituting 39.7 % of the 
group of obese women 
4.2.1 Anthropometric measures and blood samples  
Women with pre-PCOS had significantly higher body weight and height (p< 0.05), 
and waist circumference (p< 0.01) than women with FTI ≤ 0.6. The concentration of 
triglycerides tended to be higher in the pre-PCOS group (p=0.073) (table 17). 
Table 17. Characteristics of the obese pre-PCOS (FTI>0.6) women and the 
obese women with lower FTI (≤ 0.6). Anthropometric measures and lipid 
profile, (median values, point estimates for difference with 95 % confidence 
interval are given where statistically significant differences were 
observed)*   
CHARACTERISTICS 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Age (y) 41.8 41.9 - - 0.402 
Weight (kg) 118.0 128.9 -7.7 (-15.0 : -0.5) 0.034 
Height (cm) 166.0 169.5 -0.03 (-0.1 ; 0.0) 0.034 
Body Mass Index (kg/m²)  43.1 44.1 - - 0.212 
Waist circumference (cm) 125.5 133.0 -6.0 (-11.0 ; -1.0) 0.011 
Hip circumference (cm) 135.0 139.5 - - 0.106 
Waist-to-hip ratio 0.93 0.95 - - 0.120 
Total cholesterol (mmol/L) 5.1 5.3 - - 0.540 
LDL-cholesterol (mmol/L) 3.2 3.3 - - 0.612 
HDL-cholesterol (mmol/L) 1.2 1.1 - - 0.121 
Triglycerides (mmol/L) 1.4 (1.56‡) 1.5 (1.67‡) -0.2 (-0.4 ; -0.0) 0.073 ** 
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* Differences between the obese pre-PCOS women and the obese women with lower FTI 
were tested with the Mann-Whitney U test. 
** The difference tended to be significantly different 
‡ mean values 
4.2.2 Adipokines 
The serum concentrations of adiponectin in plasma tended to be lower (p= 0.069) in 
the group of females with pre-PCOS, whereas there was no statistically significant 
difference in the levels of leptin (table 18).   
Table 18. Adipokine profile among the obese pre-PCOS (FTI>0.6) women 
and the obese women with lower FTI (≤ 0.6) (median values, point estimates 
for difference with 95 % confidence interval are given where statistically 
significant differences were observed)*   
ADIPOKINE PROFILE 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Leptin (ng/ml) 59.9 60.9 - - 0.666 
Adiponectin (ng/ml) 5615 4926 1040 (-91 ; 2226) 0.069 ** 
* Differences between the obese pre-PCOS women and the obese women with lower FTI 
were tested with the Mann-Whitney U test.             
** The difference tended to be significantly different.  
4.2.3 Energy intake and macronutrients  
The obese pre-PCOS women reported significantly higher intake of polyunsaturated 
fat compared to the obese women with lower FTI score. The reported energy intake 
was similar between the groups (not significantly different), but the intake of protein 
and total fat tended to be higher among the women with pre-PCOS status (table 19).  
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Table 19. Intake of macronutrients among the obese pre-PCOS (FTI>0.6) 
women and the obese women with lower FTI (≤ 0.6) (median, point estimate 
for difference with 95 % confidence interval are given when significant 
difference between the groups were observed) * 
MACRONUTRIENTS 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Energy intake (kcal) 2577 2612 - - 0.167 
Protein intake (g) 102 107 -11.1 (-23.0 ; 0.6) 0.068** 
Fat intake (g) 104 114 -16.9 (-34.4 ; -2.6) 0.091** 
   -saturated fat (g) 41 45 - - 0.125 
   -monounsaturated fat (g) 37 38 - - 0.132 
   -polyunsaturated fat (g) 19 23 -4.7 (-8.4 ; -0.9) 0.019 
Cholesterol (mg) 327 328 - - 0.178 
Carbohydrate intake (g) 281 290 - - 0.333 
   -sugar intake (g) 41 39 - - 0.851 
Dietary fibre intake (g) 26 25 - - 0.782 
Alcohol consumption (g) 1 1 - - 0.626 
* Differences between the obese pre-PCOS women and the obese women with lower FTI 
were tested with the Mann-Whitney U test.             
** The difference tended to be significantly different  
 
4.2.4 Intake of food items  
The pre-PCOS women reported a significantly higher consumption of potatoes (also 
fresh potatoes), meat products and forcemeat, butter, margarine and oil than women 
with lower FTI score. The pre-PCOS women tended to drink more light squash and 
soft drinks (p= 0.097), and the intake of artificially sweetened soft drinks was 
significantly higher compared to the women with FTI ≤ 0.6 (p < 0.05). Table 20 
summarizes the median intake of food items, reported by the obese pre-PCOS women 
and the obese women with lower FTI score.  
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Table 20. Reported daily intake of food items (g/day) among the pre-PCOS 
(FTI>0.6) women and the women with lower FTI (≤ 0.6) according to 
dietary interview based on a FFQ (median values, point estimates for 
difference with 95 % confidence interval are given where statistically 
significant difference were observed) * 
FOOD ITEMS (gram/day) 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Total intake 3611 3751 -   - 0.307 
Bread 181 194  -  - 0.174 
White bread 0 0  -  - 0.509 
Whole-grain bread 80 80  -  - 0.93 
Cereal products 59 54  -  - 0.824 
Cakes 20 25  -  - 0.343 
Potato 57 (62.3‡) 79 (85.3‡) -24.7          (-39.4 ; -6.4)   0.006       
Fresh potatoes 50  (47.4‡) 52  (68.6‡) -24.8           (-35.2 ; -0.8)   0.011       
Pommes frites 4 5  -  - 0.727 
Vegetables 250 235  -  - 0.917 
Fruits, berries 186 192  -  - 0.733 
Meat, blood, entrails/pluck 161 203 -49.3 (-81.7 ; -14.9) 0.003 
Whole meat, minced meat 65 66 -   - 0.479 
Forcemeat 63 95 -29.0 (-48.9 ; -8.0) 0.007 
Fish, shellfish 52 56  - -  0.699 
Fish spreads 9 9  - - 0.508 
Egg 16 16  - -  0.437 
Milk, cream, ice cream 270 328  - -  0.114 
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FOOD ITEMS (gram/day) 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Whole milk 0 0  - -  0.345 
Partly-skimmed milk 58 25  -  - 0.833 
Skimmed milk 0 (23.2 ‡) 0 (62‡) 0 (-0.0 ; -0.0) 0.003 
Yogurt 14 20  -   0.448 
Ice cream 7 11  -  - 0.319 
Cheese 38 38  -  - 0.593 
Butter, margarine, oil 35 47 -15.4 (-26.1; -3.2) 0.014 
Oil, other fat 1 1  -  - 0.174 
Sugar, sweet stuff 25 31 -  - 0.669 
Chocolate 13 17  -  - 0.677 
Sweets 4 6  - -  0.271 
Drinks 1709 1744  - -  0.838 
Coffee 150 240  - -  0.947 
Tea 0 0  - -  0.379 
Squash/ soft drink, with sugar 0 0  - -  0.982 
Soft drink with sugar 0 0  - -  0.952 
Squash with sugar 0 0  - -  0.123 
Squash/ soft drink, light 210 423 -116.0 (-289.9 ; 1.1) 0.097** 
Soft drink, artificially 
sweetened  133 323 -98.0 (-235.2 ; -0.1) 0.044 
Water, mineral water  698 576  -  - 0.226 
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FOOD ITEMS (gram/day) 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Beer 4 0  -  - 0.401 
Wine, liquor 3 3  -  - 0.465 
Various 148 174  -  - 0.68 
Potato chips 4 7 -  -  0.216 
Other snacks 0 0 -  -  0.603 
Fatty fruit, seeds 3 1 0.0 (0.0 ; 3.0) 0.062** 
* Differences in reported intake of food in obese and control women were tested with the 
Mann-Whitney U test 
** The difference tended to be significantly different 
‡ mean intake 
4.2.5 Accuracy of reported food intake 
We presumed that the obese women had a sedentary lifestyle; however, since they are 
obese, they have increased energy cost due to weight bearing activities. Therefore we 
decided to use a PAL value of 1.6 to predict the total energy expenditure among the 
obese women with and without pre-PCOS status. 
Energy reporting among obese pre-PCOS women versus obese women 
The estimated resting metabolic rate multiplied with a PAL factor of 1.6 resulted in 
estimated total energy expenditures, which were significant different between the 
obese pre-PCOS women and the other obese women. The energy requirements 
among women with FTI ≤ 0.6 and the pre PCOS women, to maintain stable body 
weight, were 2926 and 3105 kcal, respectively. When subtracting the estimated TEE 
from the reported energy intake, the women with low FTI under-reported 584 kcal 
(median) versus the pre-PCOS women who under-reported approximately 531 kcal 
per day (median) (table 21). 
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Table 21. Accuracy of reported food intake among the obese pre-PCOS 
(FTI>0.6) women and the obese women with lower FTI (≤ 0.6) (median, 
point estimate for difference with 95 % confidence interval are given where 
statistically significant differences were observed). 
ACCURACY OF 
REPORTED ENERGY 
INTAKE 
Obese 
women 
FTI ≤ 0.6 
(n=68) 
pre-PCOS 
Obese 
women 
FTI > 0.6 
(n=46) 
Point estimate 
for difference 95 % CI p-value * 
Reported EI (kcal) 2577 2612 - - 0.167 
RMR (kcal) 1828 1940 -100.5 (-173.4 ; -21.3) 0.012 
PAL  1.6 1.6 - - - 
eTEE (kcal) 2926 3105 -160.9 (-277.4 ; -34.1) 0.012 
EI - eTEE (kcal) -584 -531 - - 0.439 
* Differences between the pre-PCOS women and the women with lower FTI were tested 
with the Mann-Whitney U test.                  
EI = energy intake. RMR = resting metabolic rate. PAL = physical activity level. e TEE = 
estimated total energy expenditure.  
 
The number of under-reporters (rEI – eTEE < 0) among women with lower FTI was 
49 (72 %), and they underreported in median 874 kcal, constituting 29 % of the total 
estimated energy requirement (table 22). Among the obese pre-PCOS women the 
number of under-reporters was 30 (65%). The underreported value constituted 851 
kcal; 26 % of the total estimated energy expenditure. On the other hand, 19 women 
with low FTI non-underreported (27.9%) and the misreported value was 534 kcal 
above the estimated requirement (18.7 %). Sixteen of the pre-PCOS women 
misreported median 632 kcal; 19 % extra energy compared to the estimated total 
requirement. All in all, we did not find any difference between the obese pre-PCOS 
women and the obese women in regard to under- and over reporting.  
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Table 22. Number of under-reporters and non-under-reporters among the 
pre-PCOS (FTI>0.6) women and the women with lower FTI (≤ 0.6) 
(median). Amount of misreporting energy intake compared to the estimated 
total energy expenditure (rEI-eTEE) are given in absolute values and 
percentages (median)*  
Obese women  
FTI ≤ 0.6  
(n=68) 
pre-PCOS  
Obese women 
FTI > 0.6 
(n=46) 
UNDER-REPORTERS VERSUS 
NON-UNDER-REPORTERS 
 
 
Under-
reporters 
Non-under-
reporters 
Under-
reporters 
Non-under-
reporters 
Number (n) 49 19 30 16 
Number (%) 72.1 27.9 65.2 34.8 
Misreported value (kcal)  -874 534 -851 632 
Misreported value (%) -29.2 18.7 -26.1 19.0 
* Differences between the under-reporters and non-under-reporters among the pre-PCOS 
women and the women with lower FTI were tested with the Mann-Whitney U test. We did 
not find any significant differences.  
4.3 PCOS women and effect of weight loss – preliminary 
results of the FEMIN study  
4.3.1 Effects of a low-calorie-diet on different parameters among 
PCOS women 
To achieve weight reduction in the women participating in the FEMIN study, two 
different low-calorie-diets were used, however the total calorie intake were similar in 
the two diets. Therefore, we first wanted to investigate the effects of low-calorie-diets 
on different parameters among the nine PCOS women in our study, independently of 
which diet they were randomized to. 
Effect of a LCD on anthropometric measures, body composition and 
blood pressure 
After eight weeks consuming a low-calorie-diet, the obese PCOS women 
significantly reduced their weight, BMI, waist-, hip- and neck circumferences, as 
expected. The participating women reduced their weight on average with 7.4 ± 6.2 
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kg, and this constitutes a mean percentage weight loss of 6.3 % of total body weight 
at baseline. Furthermore, the weight alteration among the obese women ranged from -
14.4 kg (-10.9 %) to +4.4 kg (+4.2 %). In accordance with the weight reduction, the 
women’s body compositions were altered. The PCOS women lost significant 
amounts of both fat mass and fat free mass. At baseline the analysis of body 
composition detected a mean fat mass percentage of 49.0 % among the PCOS 
women, and after eight weeks on diet the fat percentage was reduced to 47.4 %, 
which tended to be significant. The women had a decrease of 9.7 % in total fat mass. 
The loss of fat free mass constituted 25.1 % of the total body weight loss. Even 
though the women significantly lost muscle mass (in kg) during the low-calorie-diet 
period, their percentage of muscle mass, after the eight weeks, tended to be increased 
compared to baseline. Baseline data and measurements after eight weeks on LCD are 
summarized, together with the achieved differences ([Δ], baseline data – eight weeks 
data) between these two measurements in table 23.  
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Table 23. Effect of LCD on anthropometric measures, body composition 
and blood pressure among obese PCOS women. Data from baseline and 
after eight weeks on LCD are given (mean values), together with the 
achieved differences ([Δ], baseline data – eight weeks data) (mean values) 
between these two measurements (95 % confidence interval for the 
difference). * 
ANTHROPOMETRY, 
BODY COMPOSITION 
AND BLOOD PRESSURE 
Baseline 
(n=9) 
After 8 wks
(n=9) 
 
Mean 
difference (Δ) 95 % CI p-value * 
Age (years) 28.7 ± 6.3 28.7 ± 6.3 - - - 
Weight (kg) 116.9 ± 11.5 109.5 ± 9.2 7.4 (2.7 ; 12.2) 0.007 
Height (cm) 169.8 ± 4.5 169.8 ± 4.5 - - - 
BMI (kg/m²) 40.6 ± 4.7 38.0 ± 3.2 2.6 (0.9 ; 4.3) 0.008 
Waist circumference (cm) 120.9 ± 6.4 114.9 ± 5.9 5.9 (2.8 ; 9.0) 0.002 
Hip circumference (cm) 130.5 ± 8.6 125.3 ± 8.4 5.2 (0.8 ; 9.6) 0.025 
Waist to hip ratio 0.93 ± 0.06 0.92 ± 0.06 0.01 (-0.01 ; 0.02) 0.233 
Neck circumference (cm) 40.3 ± 2.6  38.8 ± 1.9 1.5 (0.6 ; 2.4) 0.005 
Fat mass (kg) 57.5 ± 8.9 51.9 ± 5.5 5.6 (1.2 ; 10.0) 0.019 
Fat percent (%) 49.0 ± 4.2  47.4 ± 2.9 1.6 (-0.3 ; 3.5) 0.081 ** 
Fat free mass (kg) 59.4 ± 6.0 57.5 ± 5.8  1.9 (0.6 ; 3.1) 0.008 
Muscle mass (kg) 56.4 ± 5.6 54.6 ± 5.4  1.8 (0.7 ; 2.9) 0.006 
Muscle percent (%) 48.4 ± 4.0  49.9 ± 2.7 -1.5 (-3.3 ; 0.3) 0.085 ** 
Systolic blood pressure 
(mmHG) 130 ± 16.4 125 ± 8.6  5.2 (-6.0 ; 16.4) 0.313 
Diastolic blood pressure 
(mmHG) 91 ± 8.0 86 ± 7.7 4.9 (-2.8 ; 12.6) 0.181 
* The achieved differences ([Δ] baseline measurements - eight weeks measurements) were 
investigated with the One Sample t-test. 
** The achieved difference tended to be significant 
Effect of LCD on lipid profile, CRP and adipokines 
The participating PCOS women had increased level of LDL cholesterol (mean) at 
baseline, whereas the other lipid parameters (mean values) were within the 
recommended range. The mean concentrations of apolipoprotein B and 
apolipoprotein A-I were within their reference values (0.5-1.3 g/L and 1.2-2.3 g/L), 
while the level of CRP was above the reference value (<4 mg/L) (131). After eight 
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weeks on low-calorie-diet, the level of apolipoprotein A-I was significantly lowered, 
while the level of triglycerides tended to be reduced. Furthermore, the leptin 
concentration was significantly lowered after the diet period. The achieved difference 
in leptin concentration was statistically positively correlated to the leptin 
concentration at baseline (rho=0.83, p=0.005) and the achieved difference in body 
weight from baseline to eight weeks measurement (rho= 0.67, p=0.05). Baseline data 
and measurements after eight weeks on LCD are summarized, together with the 
achieved differences ([Δ], baseline data – eight weeks data) between these two 
measurements in table 24. 
Table 24. Effect of LCD on lipid profile, CRP and adipokines among obese 
PCOS women. . Data from baseline and after eight weeks on LCD are given 
(mean values), together with the achieved differences ([Δ], baseline data – 
eight weeks data) (mean values) between these two measurements (95 % 
confidence interval for the difference) * 
BLOOD PROFILE 
Baseline 
(n=9) 
After 8 wks
(n=9) 
Mean 
difference (Δ) 95 % CI p-value * 
Total cholesterol (mmol/l) 5.0 ± 0.9 4.8 ± 1.0 0.3 (-0.4 ;0.9) 0.362 
HDL cholesterol (mmol/l) 1.2 ± 0.3 1.2 ± 0.3 0.1 (-0.1 ; 0.2) 0.397 
LDL cholesterol (mmol/L) 3.23 ± 0.6 3.0 ± 0.8  0.2 (-0.3 ; 0.8) 0.371 
Triglycerides (mmol/l) 1.2 ± 0.7 1.0 ± 0.7 0.2 (-0.0 ; 0.4) 0.057 ** 
Apolipoprotein B (g/L) 0.9 ± 0.2 0.8 ± 0.2 0.1 (-0.0 ; 0.2) 0.174 
Apolipoprotein A-I (g/L) 1.5 ± 0.3 1.3 ± 0.2 0.3 (0.0 ; 0.5) 0.025 
ApoB/ApoA-I 0.59 ± 0.2 0.65 ± 0.27 -0.1 (-0.2 ; 0.1) 0.271 
CRP (mg/L) 9.3 ± 8.0 8.5 ± 6.7 0.8 (-1.2 ; 2.8) 0.384 
Adiponectin (ng/ml) 2233 ± 840 2306 ± 714 -73.1 (-282.6 ; 136.4) 0.444 
Leptin (ng/ml) 77.7 ± 18.2 51.2 ± 12.5 26.4 (13.7 ; 39.2) 0.001 
* The achieved differences ([Δ] baseline measurements - eight weeks measurements) were 
investigated with the One Sample t-test.          
** The achieved difference tended to be significant 
 89
4.3.2 Effects of two different low-calorie-diets on different 
parameters among PCOS women 
We wanted to investigate if the low-calorie-diets; the crisp bread diet and the powder 
diet, induced different changes (Δ) on the parameters among the nine PCOS women 
after completion of the eight weeks with diet. At baseline, the women in the two 
different low-calorie-diet groups did not differ with regard to anthropometric 
measures, body composition, lipid profile and blood pressure. A significant 
difference in leptin levels (p = 0.05) was detected between the two groups. The 
women in the powder diet group had lower levels of leptin at baseline.  
Effects of two different LCDs on anthropometric measures, body 
composition and blood pressure 
The achieved differences ([Δ], baseline data – eight weeks data) in anthropometry 
and body composition from baseline to the eight weeks measurements were not 
significant different between the two low-calorie-diet groups (table 25). However, 
there tended to be a difference in systolic blood pressure from baseline to the eight 
weeks measurement where a reduction tended to be more pronounced in the powder 
diet group than in the crisp bread diet group.   
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Table 25. Effects of two different LCDs on anthropometric measures, body 
composition and blood pressure among obese women with PCOS. Data 
from baseline and after eight weeks on the diets are shown (mean values 
and standard deviation)* 
Crisp bread diet 
 Powder diet  
COMPARISON 
BETWEEN THE TWO 
DIETS 
 
Baseline 
(n=5) 
After 8 wks 
(n=5) 
Baseline 
(n=4) 
After 8 wks 
(n=4) 
p-value 
* 
Age (years) 27.6 ± 8.4 27.6 ± 8.4 30 ± 2.9 30 ± 2.9 - 
Weight (kg) 118.9 ± 10 111.4 ± 6.5 114.4 ± 14.3 107.0 ± 12.4 0.993 
Height (cm) 169 ± 6.0 169 ± 6.0 170.8 ± 2.2 170.8 ± 2.2 - 
BMI (kg/m²) 41.8 ± 5.2 39.1 ± 2.7 39.2 ± 4.2 36.7 ± 3.6 0.895 
Waist circumference (cm) 123.2 ± 6.2 117.9 ± 5.0 118 ± 6.2 111.3 ± 5.2 0.625 
Hip circumference (cm) 131.9 ± 11.1 126.9 ± 9.1 128.8 ± 4.9 123.3 ± 8.3 0.906 
Waist to hip ratio 0.94 ± 0.06 0.93 ± 0.04 0.92 ± 0.07 0.91 ± 0.08 0.686 
Neck circumference (cm) 41.1 ± 3.0 39.7 ± 2.2 39.3 ± 1.7 37.6 ± 0.5 0.796 
Fat mass (kg) 59.3 ± 10.3 54 ± 4.6 55.3 ± 7.5 49.4 ± 6.1 0.879 
Fat percent (%) 49.6 ± 5.3 48.4 ± 2.5 48.3 ± 3 46.2 ± 3.2 0.585 
Fat free mass (kg) 59.6 ± 4.5 57.5 ± 3.9 59.1 ± 8.2 57.6 ± 8.2 0.556 
Muscle mass (kg) 56.6 ± 4.2 54.5 ± 3.7 56.1 ± 7.8 54.7 ± 7.7 0.527 
Muscle percent (%) 47.9 ± 5.0 48.9 ± 2.3 49.0 ± 2.9 51.1 ± 3.01 0.577 
Systolic blood pressure 
(mmHG) 123 ± 15.2 125 ± 11.5 139 ± 14.9 125 ± 4.3 0.095 **
Diastolic blood pressure 
(mmHG) 92 ± 8.2 87 ± 10.2 91 ± 9.0 86 ± 4.4 0.930 
* The achieved differences ([Δ] baseline measurements - eight weeks measurements) were 
compared between the two diet groups, using the Independent Samples t-test. 
 ** The achieved difference between the groups tended to be significant. 
Effects of two different LCDs on lipid profile, CRP and adipokines 
Furthermore, we investigated the difference between two different dietary groups 
with regard to lipids, CRP and adipokines. The achieved differences ([Δ], baseline 
data – eight weeks data) for the parameters were however not significantly different 
between the two diet groups (table 26). 
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Table 26. Effects of two different LCDs on lipid profile, CRP and 
adipokines. Data from baseline and after eight weeks on the diets (mean 
and standard deviation)* 
Crisp bread diet 
 
Powder diet 
  
COMPARISON 
BETWEEN THE TWO 
DIETS 
 
Baseline 
(n=5) 
After 8 wks 
(n=5) 
Baseline 
(n=4) 
After 8 wks 
(n=4) 
p-value 
* 
Total cholesterol (mmol/l) 5.3 ± 0.8 5.3 ± 0.8 # 4.6 ± 0.9 4.0 ± 0.7 # 0.270 
HDL cholesterol (mmol/l) 1.2 ± 0.4 1.2 ± 0.3 1.3 ± 0.3 1.2 ± 0.2 0.928 
LDL cholesterol (mmol/L) 3.5 ± 0.5 3.5 ± 0.7 # 3.0 ± 0.7 2.4 ± 0.5 # 0.195 
Triglycerides (mmol/l) 1.3 ± 0.9 1.1 ± 0.9 1 ± 0.3 0.8 ± 0.4 0.906 
Apolipoprotein B (g/L) 0.9 ± 0.2 0.9 ± 0.2 # 0.8 ± 0.2 0.6 ± 0.1 # 0.238 
Apolipoprotein AI (g/L) 1.5 ± 0.3 1.2 ± 0.3 1.6 ± 0.4 1.3 ± 0.2 0.625 
ApoB/ApoAI 0.7 ± 0.2 0.8 ± 0.3 # 0.5 ± 0.1 0.5 ± 0.1 # 0.282 
CRP (mg/L) 12.1 ± 10.0 11.0 ± 8.5 5.9 ± 2.6 5.5 ± 1.5 0.744 
Adiponectin (ng/ml) 2093 ± 487 2154 ± 404 2408 ± 1221 2497 ± 1028 0.886 
Leptin (ng/ml) 88.0 ± 9.6 † 58.7 ± 10.1 ‡ 64.9 ± 19.0 † 41.9 ± 8.6 ‡ 0.604 
* The achieved differences ([Δ], baseline measurements - eight weeks measurements) were 
compared between the two diet groups, using Independent Samples t-test. 
† p=0.05, difference in this parameter between the two diet groups at baseline (tested with 
Mann Whitney U test)  
‡ p=0.05, difference in this parameter between the two diet groups at eight weeks 
measurement (tested with Mann Whitney U test)  
# Significant difference (p<0.05) in the parameters between the two diet groups at eight 
weeks measurement (tested with Mann Whitney U test) 
When comparing the eight weeks measurements between the two groups, we found 
significant differences between the two low-calorie-diet groups. The eight weeks 
measurements of total cholesterol (p = 0,049), LDL-C (p = 0,027), ApoB (p = 0,035), 
ApoB/ApoA1 (p = 0,014) and leptin (p = 0,050) were significantly different between 
these two diet groups. All the mentioned parameters were lower among the women in 
the powder diet group, compared to the crisp bread diet group 
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Figure 11. The box plots to the left illustrate the achieved differences (Δ) in 
total cholesterol, LDL-C, apo B and leptin from the measurement at 
baseline to the measurement after eight weeks on the crisp bread diet and 
the powder diet. The delta differences in the parameters were not 
significantly different between the diets. The histograms to the right 
illustrate the measurements of these parameters at baseline and after eight 
weeks for the two low-calorie-diets. At the eight weeks measurement the 
concentration of total cholesterol, LDL-C and apo B were significantly 
different between the two diet groups (not significantly different at 
baseline). At baseline and at the eight weeks measurement the concentration 
of leptin was significantly different between the two diet groups.   
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5. Discussion 
5.1 Analyses of reported food intake in the MOBIL-study 
5.1.1 The morbidly obese women versus the normal weight control 
women 
Lipid profile and expression of adipokines 
Lipid profile 
As expected, the lipid profile among the obese women was more unfavourable than 
the lipid profile observed in the lean control women. According to the National 
Cholesterol Education Program (ATP III) and the recommended concentrations of the 
different lipid parameters, total cholesterol and LDL-C (median values) were higher 
in the obese women. The median levels of triglycerides and HDL-C were within the 
cut off values. The control women had lipid values within the recommended range. 
Among our morbidly obese women, the increase in plasma cholesterol and levels of 
triglycerides may be a result of the observed higher intake of saturated fat as well as 
physical inactivity and obesity (21). Obese persons tend to have higher levels of 
triglycerides and LDL-C and reduced HDL-C concentrations (18); a tendency we also 
observed among the obese women in the present study compared to the lean control 
women. Raised levels of cholesterol in the blood are linked to atherosclerotic 
vascular disease, because elevated LDL cholesterol plays a role in the development of 
the vascular plaque (31). Our obese women also had raised levels of triglycerides 
compared to the controls, and elevated serum triglycerides are also associated with 
increased risk for coronary heart disease (20). Furthermore, the levels of triglycerides 
correlated to the waist circumference among the obese women in the present study. 
Waist circumference is a measurement of visceral adipose tissue, which again is 
associated with elevated levels of triglycerides (132).  
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Expression of adipokines 
We found significant higher levels of leptin and lower levels of adiponectin among 
the obese women compared to the control women.  
Leptin reduces appetite and enhances the energy expenditure in the body, but like 
others, we observed increased levels of leptin among the obese women compared to 
the controls. Our results correspond to previous published findings, and may be 
caused by; the increase in fat mass or support the idea about leptin resistance in obese 
subjects. In addition, higher concentrations of this parameter in obese subjects may 
not have the assumed enhanced effect in reducing appetite (46;47). Leptin levels were 
positively correlated to weight, BMI, waist- and hip circumference among our obese 
women, which may explain the significant difference in this parameter between the 
two groups. In the control group, positive correlation was seen between this 
parameter and waist circumference, LDL-C and triglycerides.  
Lower plasma concentrations of adiponectin among obese subjects have previously 
been described (49;51). They also reported a negative correlation between levels of 
adiponectin in plasma and BMI in both men and women. We found lower levels of 
adiponectin and the same negative correlation to BMI among our obese women, 
together with a negative correlation between plasma adiponectin levels and weight 
and waist circumference. The synthesis and secretion of this adipokine are decreased 
during periods of caloric excess, presumably associated with leptin deficiency or 
resistance (49). Regarding the levels of adiponectin and the association to 
dyslipidemia, we observed a significant positive correlation between this parameter 
and levels of HDL-C, while we did not find any correlation with triglycerides or 
LDL-C, as demonstrated by Matsuzawa et al (51). The lower levels of adiponectin 
among the obese women may also partly be accounted by adiponectin’s positive 
correlation with HDL-C, since the concentration of HDL-C was significantly lower in 
the obese women compared to the control subjects.  
Former studies on the association between diet and total adiponectin levels have 
demonstrated a negative correlation between total adiponectin and refined cereals, 
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while whole-grain cereals, dietary cereal fibre intake, and moderate alcohol 
consumption have been positively associated with higher levels of adiponectin (133). 
We found positive correlation between adiponectin levels and vegetables, which is a 
source for fibre, and also positive association to the intake of water; two “food 
groups” which represent healthy dietary choices. Recently Yannakoulia et al reported 
a higher percentage of energy from carbohydrates among women who had the lowest 
concentration of adiponectin (133), which supports the finding among the control 
subjects who had a negative correlation between levels of adiponectin and the 
reported intake of sugar containing squash and soft drinks. We did not find any 
correlation between alcohol and adiponectin, neither among the obese nor the 
controls.  
Energy and macronutrients intake and food choices  
Energy and macronutrients intake  
The obese women had a median intake of energy of 2603 kcal, while the control 
women had 2301 kcal as the median. This difference in 300 kcal was not statistically 
significant, using a non-parametric test. However, investigating the data with a 
parametric test, since the data were normally distributed, resulted in an almost 
significant difference in total energy intake. This indicates that the obese women 
tended to report a higher energy intake than the lean control women. Compared to the 
results from Johannsen et al (128), we saw a tendency to difference in intake of 
energy between obese and lean women, which Johannsen et al did not detect in their 
data of lean and obese women. However, the obese women in the former study had 
lower mean BMI than our obese women, while the BMI among the lean women were 
similar. Heavier women have to consume more food to maintain their weight due to 
higher RMR, and might therefore report higher intake. 
In the present study, the total intake of fat tended to be higher in the obese group 
compared to the control women; and more specifically it was the saturated fat which 
tended to be more consumed by the obese women. Higher fat intake among obese 
women compared to normal weight women have been described earlier, together with 
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an higher intake of protein and carbohydrate (134). However, we did not find any 
difference between the two groups regarding protein and carbohydrate intake. 
Previously Davis et al did not report any difference in protein intake between 
overweight/obese women (mean BMI 34) and matched normal weight women (mean 
BMI 21.2) either. However, they reported that overweight/obese women had a larger 
portion of total energy from fat, and the intake of saturated fat was significantly 
higher than among normal weight subjects. Furthermore, overweight/obese women 
had a smaller portion of total energy from carbohydrate, and especially dietary fibre 
and complex carbohydrates than normal weight women (135). In our study, the obese 
and the control women had the same intake of carbohydrates, including dietary fibre. 
Intake of the latter was satisfactory, according to the Nordic Nutrition 
Recommendations (9), and compared to the data from the Norkost Survey, our 
women, both the obese and the controls consumed more dietary fibre than the 
Norkost women (8). Our control women reported significant greater alcohol 
consumption than the obese subjects. Alcohol consumption was also higher in non-
obese subjects (BMI< 30) compared to obese subjects (BMI > 30) studied by Berg et 
al (136) and by Berteus et al (obese women mean BMI 41 and reference women 
mean BMI 23.8) (134). Compared to the Norkost Survey women, our control women 
had approximately the same intake of alcohol (8).  
Food choices 
In our study, the total intake of food (in gram) was significantly higher among the 
obese, than the control women. The obese women reported a significantly higher 
intake of meat, forcemeat and  butter/margarine/oil compared to the control women, 
and these food items may be contributing factors to the tendency of higher fat intake 
among the obese compared to the control women. Higher consumption of meat 
among overweight/obese is  previously described by Davis et al (135). Schulze et al 
suggested that a diet characterized by high intakes of red and processed meats (and 
also refined grains, sweets, desserts and potatoes) may contribute to weight gain (11). 
Furthermore, the obese women had significantly increased consumption of snacks 
(others than potato chips) compared to the control women. Previously, Berteus et al 
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reported a trend between reported snacking frequency and increased proportions of 
fat intake and decreased proportions of protein intake in obese women (and 
men)(137). In the present study, the correlations between fat intake and different food 
items suggested that the obese women ate more fat containing food items, whereas 
the fat intakes among the control subjects were restricted to fewer particularly fatty 
food items. 
Davis et al reported lower consumption of fruits among overweight/obese women 
compared to normal weight controls (daily servings of vegetables were almost 
identical) (135), but in our study the intake of both fruits and vegetables were 
reported equally between the two groups. Reported intakes of bread and diary 
products did not differ between the groups, and this coincidence with previous 
published data comparing food intake (135).  
The consumption of light soft drinks and squash were significantly increased among 
the obese women. A recent published study describing the different characteristics of 
people consuming  either soft drinks with and without sugar, described that intake of 
artificially sweetened soft drinks was associated with a higher body weight for adults. 
Consumption of light soft drinks was also related to higher restrained eating, whereas 
sugar containing soft drinks were related to less restrained eating. This may imply 
that persons with higher body weight tried to avoid calories by choosing light 
products (138), and this interpretation can be conveyed to our data material as well. 
The relationship between artificial sweeteners and control over body weight is an 
issue in dispute. Whether these sugar replacements are used by the overweight/obese 
to control the intake of calories and by that body weight, or if these substitutes could 
be a leading cause to the increasing weight problem in the population. An 
epidemiological study from 2008 questioned whether the use of artificially sweetened 
soft drinks might “fuel the obesity epidemic rather than fighting it”. They reported a 
positive dose-response relationship between the use of artificially sweetened soft 
drinks at baseline and the prevalence of overweight and obesity after seven to eight 
years (adjusted for BMI at baseline) (139). On the other hand, review of the literature 
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is inconsistent in the evaluation of the use of artificial sweeteners in soft drinks with 
regard to body weight control. Some, but not all findings support that the replacement 
of sugar by low-energy sweeteners may result in lower energy intake and better 
weight control (140). On the other hand, there are discussions about how sugar 
replacements affect satiety, metabolic mechanisms in the body, and by that energy 
intake. One view is that sweetness supplied without calories results in equivocal 
psychobiological signals that confuse the regulatory mechanisms in the body, leading 
to loss of appetite control and overeating (141). 
Selection of physical activity level 
Physical activity level in obese subjects and as well in normal weight persons is very 
subjective and difficult to state. Our obese women reported a sedentary lifestyle and 
in proportion to the defined PAL values extracted from the Nordic Nutrition, a person 
described as having a seated work with no option of moving around and little or no 
leisure activity has a PAL factor of 1.4 (9). However, NNR do not distinguish 
between normal weight subjects and morbidly obese persons. They report values for 
the population as a whole. According to other studies exploring obese subjects, the 
PAL values varies, and Hustvedt et al estimated a PAL of 1.8, due to increased 
energy expenditure during weight bearing activities. This finding was demonstrated 
among obese men and women with an average BMI of 36 using DLW and ActiReg 
(126). However, Johannesen et al found a PAL value of 1.6 among obese women 
(BMI 33), while Das et al examined morbidly obese women and found an average 
PAL of 1.6 (127;128). Based on this data, we decided to use PAL 1.6 in our group of 
obese women.  
The healthy controls were doctors, nurses and physiotherapists, indicating works with 
standing, some moving around as well as seated paper work. From NNR the PAL 
value to a person who has work including both standing and moving around, is 
between 1.8 and 1.9. However, the controls also had seated work, but they probably 
had higher physical activity in the leisure time than the “normal” population, due to 
occupancy of own health. Because of this assumption, we choose PAL of 1.8 among 
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the control women, even though this physical activity level is slightly higher than 
demonstrated in healthy normal weight Danish adults (125). According to the control 
women’s working positions and health attitude, a higher PAL value than this may be 
expected. 
In the present study we found, when using PAL 1.6 among the morbidly obese 
women and PAL 1.8 among the control subjects, an underreported amount of 570 
kcal (17 %) among the obese women, while the median reported food intake among 
the controls matched the estimated energy expenditure for this group.  
Comparing the TEE with the reported energy intake for the obese women, they 
underreported approximately 17 %, which is consistent with findings from other 
studies. Svendsen et al demonstrated an underreporting of 20.6 % of energy intake 
compared to the estimated EE when using FFQ (119). However, in the OPEN study 
they found among women (normal weight and obese) an underreporting of energy 
compared to total EE as high as 34-38 % when compared to reported intake obtained 
by FFQs, and 16-20 % underreporting when compared with 24-hour dietary recall. 
(142). The obese women in the OPEN study reported an energy intake of 80 % of 
their energy requirement according to FFQ, and 71 % of the energy requirement 
based on 24-hour dietary recall (143).  
In the present study (using PAL 1.6 for the obese women), investigating the under-
reporters separately, we found 69.8 % of the obese women to be under-reporters, 
which is a higher percentage of under-reporters than previously described. Svendsen 
et al reported that 59 % of the obese women underreported, using a FFQ (119), while 
in the OPEN study they demonstrated 57 % underreporting among obese men and 
women (n=142) when using a FFQ. For all the women (n=223), 49 % underreported, 
while 46.7 % of the obese women (n=65) underreported their energy intake (142). 
Since the amount of under-reporters in our study was higher than previous findings, 
we also calculated the TEE based on a lower PAL value; 1.4, in accordance with the 
definition of PAL 1.4 in NNR (seated work with no option of moving around and 
little or no leisure activity). When using PAL 1.4 in the calculation of TEE we 
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achieved a better correlation to previous published findings of the estimation of 
under-reporters. By “lowering” the energy expenditure, fewer women became under-
reporters, now constituting 59.5 % (results not shown), very close to what Svendsen 
et al reported (119). However, the definition of under-reporters plays a major role in 
the calculation of under-reporters (see next section). On the other hand, the results 
obtained with the use of a PAL value of 1.4, lead to a median underreported value 
among all the obese women which was much smaller (5.6 %) and very different, 
compared to previous published findings (117;119). This further supported our 
choice of PAL 1.6 among the obese women. However, another point of view, is that 
several of the obese women in the MOBIL-study might have been in a weight 
reduction phase (no information was obtained on this topic), thereby reporting a 
lower energy intake than the estimated expenditure (EI < EE = weight loss), without 
actually underreporting their food intake. We might have misclassified these women 
as under-reporters  
One may discuss whether the control women reported correctly, or if our estimation 
of physical activity level was too low. Other studies indicate that underestimation to 
some extent of food intake is common, independently of adiposity (117;118;144). If 
the control subjects underreported and the energy account were “break even”, the 
controls might have a PAL greater than 1.8. This is not unlikely due to the control 
women’s work and the high assumed activity level in their leisure time. However, the 
controls were highly motivated health workers, instructed to be specifically accurate 
during the food frequency questionnaire interview, so the measurements may be 
valid, resulting in a match between the estimated energy expenditure and the reported 
food intake, giving energy balance and stable weight. Compared to the mean intake 
among women aged 30 – 54 years in the Norkost Survey, which was 1864 kcal, our 
control women reported a higher median energy intake (8). But our control group did 
not represent a normal, healthy and lean control group. They were all health workers 
which have more active jobs. As health workers they are probably more occupied 
with their own health and lifestyle, including eating more healthy food and exercise 
more than average.  
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Definition of under-reporters 
The definition of under-reporters can be discussed. We used a simple calculation to 
estimate the number of under-reporters and the number of non-under-reporters, 
calculated as the reported energy intake minus the estimated total energy expenditure. 
Subjects with negative outcome of this calculation were classified as under-reporters, 
while positive outcome resulted in non-under-reporters. In other words, all subjects 
having only a slightly lower energy intake compared to estimated TEE were 
classified as under-reporters, even though the difference only constituted a few 
kilocalories. Svendsen et al. identified under-reporters based on the 95 % confidence 
limits of the expected EI: TEE ratio of 1.0. Subjects with a ratio below this limit were 
classified as under-reporters. They also identified accurate-reporters who had their 
EI: TEE ratio in between the limits. Taken this into consideration, a simple and 
appropriate definition of accurate-reporters in our study could be the energy intake 
minus energy expenditure is zero plus/minus 200 kcal (equivalent to two slices of 
bread, one with ham, the other with cheese). The amount of accurate-reporters in our 
data material will then be 12 of the obese women. Nine of these 12 accurate-reporters 
were originally classified as under-reporters, and the “new” percent of under-
reporters will be 62 %, compared to 69.8 % originally. This is more consistent with 
the reported percent of under-reporters (59.3 %) among obese women in the study by 
Svendsen et al (119). If we used PAL 1.4 among the obese women and extracted the 
accurate-reporters from the underreporting group, percent under-reporters among the 
obese would be 48.3 %, which is very consistent with the findings among women in 
the OPEN study (143).  
Another and frequently used method to define under reporters is to calculate the EI: 
BMR ratio. According to Goldberg et al, the cut off value representing a reported 
energy intake that may be representative of long-term energy intake, and which is 
compatible with a normal lifestyle (not bedbound) is 1.35. EI: BMR lower than 1.35 
is regarded as underreporting (118;145). This cut off value represent almost the same 
value as we used when we stated that the obese women reporting energy intake lower 
than the estimated BMR multiplied with 1.4, were under-reporters. If we had used 
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Goldberg’s cut off (using RMR predicted by Mifflin St-Jeor, in lack of BMR), 61 
(52.6 %) of the obese women would have been under-reporters.  
Estimating the resting metabolic rate 
To estimate the resting metabolic rate, we used the Mifflin-St Jeor equation, both for 
the obese and the control women. This predictive equation is based on a data set that 
included normal weight, overweight, obese and severely obese subjects, making the 
equation more valid for obese persons, than other equations which are based 
predominantly on normal weight subjects. These equations, as the Harris Benedict 
equation, are more commonly used to estimate EE among normal weight persons. We 
used the same equation (Mifflin St-Jeor) for both the lean and the obese women. It is 
discussable whether this is a source for wrong estimation of RMR, since other 
equations as the Harris Benedict may be a better equation for the lean, control group. 
However, in 2005, the American Dietetic Association analyzed different predictive 
equations for resting metabolic rate. The Mifflin-St Jeor equation performed best with 
regard of accurately measurement of RMR, both among obese and normal weight 
subjects. Based on the systematic review of the literature, they recommended the 
Mifflin-St Jeor equation to estimate RMR (122). The difference between the 
calculated RMRs from the two equations is minor. When using the median data of the 
control women in the two equations, Mifflin St-Jeor yielded 70 kcal less in estimated 
RMR compared to Harris Benedict (weight 65 kg, height 168 cm, age 44 years 
[medians] estimating RMR of 1321.9 kcal for Mifflin and 1390.1 kcal for Harris). 
We estimated RMR by both Mifflin St-Jeor and Harris Benedict equation for the 
obese and the control women, and subtracting the estimated RMR amount of Harris 
Benedict from the estimated RMR amount of Mifflin St-Jeor. The median difference 
between these two equations was 44 kcal for the obese women, whereas among the 
controls the Harris Benedict estimated 71 kcal more in RMR than Mifflin St-Jeor. It 
is unlikely that this would influence our results, but if we had used the Harris 
Benedict equation the estimated amount of underreported kcal would be slightly 
different. With Harris Benedict predicting RMR calculated with PAL 1.8 among the 
 104 
control women, the estimated TEE would exceed the reported energy intake, stating 
more underreporting than the Mifflin St-Jeor equation among the control women. 
With regard to previously reported findings that normal weights also underreport 
their food intake (118;144), this calculation might be more accurate, but there are 
only small differences in the estimation of energy expenditure compared to the 
reported energy intake. Furthermore, our control women are not a representative 
selection of women, and we think they may be more accurate in their reporting, and 
the accurate estimation of EI versus EE using Mifflin St-Jeor and PAL 1.8 might be 
right for this control group. Using Harris Benedict for the obese women would 
increase the underreported amount of kcal.   
Reasons for under-reporting 
Our control women reported accurately when we used a PAL value of 1.8, while the 
obese women (PAL 1.6) underreported approximately 570 kcal (median). Previous 
studies have supported the assumption that underreporting becomes more common as 
body weight increases. Still, underestimation of energy intake is also common among 
non-obese subjects (116). Even though the obese women underreported the EI, they 
simultaneously reported an intake of energy of 300 kcal more than the control 
women. This difference of 300 kcal tended to be significantly different. Significant 
difference between the reported EI among obese women and controls was found in a 
study by Berteus et al. The Swedish obese women (BMI 38.1 ± 4.5 kg/m²) had an 
energy intake which were approximately the same as in our study, but it was 
significant different from the reference group of lean women (it is likely that our 
control women had an higher EI due to higher physical activity level) (137).  
Since the estimated TEE was significantly higher among the obese than the control 
women, an accurately reported EI could be expected to be significant different 
between the two groups as well. This non significant difference between the obese 
and the controls, and why underreporting is an issue, can be explained by several 
factors. Hill et al have summarized characteristics of under-reporters and proposed 
mechanisms for underreporting. Higher educational level and social class has been 
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associated with better correlation between reported EI and the estimated TEE (116). 
Our controls were health workers; doctors, nurses and physiotherapists, and were all 
subjects with higher educational achievement and thereby presumable a higher social 
class. Furthermore, Hill et al characterizes under-reporting persons as possible 
restrained eaters who have increased concerns about their body weight and poor body 
image (116). In obese subjects the reported intake may actually be lower in periods 
due to dieting (dietary restraint) and an attempt to weight reduction. On the other 
hand, other periods may be filled with binge eating and perhaps compulsive eating 
contributing to the weight gain. During these periods, most likely the obese subject 
will not seek medical centres, due to bad self efficacy. It is not unlikely that the 
interception of this dietary pattern and food choices not will be included in a study 
seeking information about dietary history in obese persons. FFQs often focus on the 
diet during the last year, but intakes during the last months may be easier to 
remember, than recalling the food intake eight months ago. In a period with dietary 
restraint an obese person diet report may actually be precisely and describe the actual 
intake, but the periods of binge eating which has brought this person to the obesity 
scale is forgotten, and comes off the record.  Furthermore, there might be great 
differences between weekdays and weekends. The diet through the week might be 
reasonable healthy, while during the weekends the intake may include very calorie 
dense food (such as sweets, cakes, junk foods and alcohol). Most likely the diet 
through weekdays may be easier to recall and generalize because of more routines 
and rhythm these days than weekends. Subjects visiting a nutritionist to give a dietary 
interview may have a deliberate or subconscious intention to report a healthier diet 
than normally consumed. Underreporting may be manifested by failure to report 
eating occasions or to report eating occasions incorrectly, misreport in the quantity 
eaten, or maybe a combination of these together, or denial of food consumption 
(116;146). All put together, diet among obese subjects may be difficult to define, and 
to detect the representative normal diet during a period of time.  
Previous published findings have tried to detect the difference in food intakes 
between under-reporters and non-under-reporters. Lafay et al demonstrated a higher 
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contribution of snacks to the total energy intake among normal weight, middle aged 
non-under-reporters compared to the ones who underreported. Lunch and dinner, for 
underreporting men and women respectively, contributed to a higher extent to the 
total energy intake. Food items such as butter, dairy desserts, sugars and 
confectionery, cakes/pastry/biscuits, French fries and to a lesser extent fruit were 
significantly less frequently reported by the underreporting men and women. Food 
items reported equally between non-under-reporters and under-reporters were 
vegetables, green vegetables, fish and meat (120). By looking at the diet history of 50 
obese persons studied by Svendsen et al, the researchers revealed by the dietary 
record a lower intake of “sweets, desserts and snacks” and drinks with sugar among 
the under-reporters compared to the non-under-reporters. The under-reporters also 
had a higher energy percent from protein, and a lower energy percent from sugar 
compared to non-under-reporters. However, the reported absolute intake of protein 
was lower in the under-reporting group. According to both FFQ and DR, sweets, 
desserts and snacks was inversely related to energy percent from protein. Diet history 
obtained by FFQ revealed that accuracy in food intake reporting was inversely 
correlated to the percentage energy from protein and positively correlated to energy 
percent from sugar (119). 
5.1.2 Obese pre-PCOS women versus obese women 
In our lack of a PCOS diagnosis among the obese women in the MOBIL-study, we 
used a surrogate marker, the free testosterone index, and classified women having a 
FTI score above 0.6 to be pre-PCOS subjects. In the real diagnosis of PCOS, 
hyperandrogenemia is one out of the three diagnostic criteria; and the women have to 
satisfy two of the criteria to be diagnosed. By using only the FTI score as a 
“diagnostic criteria”, we classified 46 out of the 116 obese women to have pre-PCOS 
status. This is almost 40 % of the obese women, which is a higher prevalence of 
PCOS in a obese population compared to previously published studies on PCOS 
among overweight and obese women (58;59).      
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Anthropometry 
The obese women with pre-PCOS diagnosis were significant heavier than the obese 
women with free testosterone index below 0.6, and the waist circumferences were 
also significantly higher, suggesting a more android fat distribution among the pre-
PCOS women. Carmina et al investigated the abdominal fat among women with 
PCOS compared to weight matched controls. They found similar quantity of total fat 
and trunk fat in these two groups, but only the normoweight and overweight women 
with PCOS had increased central abdominal fat compared to the controls, not the 
obese women with PCOS (72). On the other hand, Cascella et al examined 
overweight PCOS women and reported larger waist circumference among these 
women compared to age- and BMI-matched controls (71). Furthermore, measurement 
of waist circumference is valuable to identify people who are at increased risk to 
develop obesity-related illness, due to accumulation of abdominal fat tissue. The pre-
PCOS women who had elevated waist circumference compared to the women with 
lower FTI score, may possess more risk factors for cardiovascular disease (41). 
Lipid profile 
Dyslipidemia is reported to be common among women with PCOS, characterized by 
increased levels of triglycerides and small, dense LDL particles and decreased 
concentration of HDL-C (68;76).With regard to levels of LDL-C and HDL-C, we did 
not find a more unfavourable status among the obese pre-PCOS women compared to 
the obese women. However, the levels of triglycerides tended to be greater in the pre-
PCOS women. Enhanced levels of triglycerides in women with PCOS have been 
described previously. Pirwany et al found significant difference from BMI matched 
controls (77), and Legro et al reported significant higher triglyceride values in PCOS 
women compared to BMI matched controls, but after adjusting for age, BMI, waist-
to-hip ratio, and fasting insulin and glucose levels, the difference was present but not 
significantly different (80).  
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Adipokines 
Previous studies done on women diagnosed with PCOS, have reported significantly 
lower levels of adiponectin in these women compared to weight-matched controls 
(147). Among our obese pre-PCOS women, the adiponectin levels, tended to be 
lower compared to the obese women with FTI below 0.6. Leptin levels were equally 
between the groups, and this result correspond to previous published findings that 
leptin levels have been related to BMI rather than other metabolic or hormonal 
disturbances in women with PCOS (82).  
Reported food intake 
The pre-PCOS women tended to have a higher intake of protein and fat compared to 
women with lower FTI score, the intake of polyunsaturated fat was significant higher. 
There are limited data on the dietary history of women with PCOS. Douglas et al 
compared the dietary profile to overweight women with PCOS with age-, race- and 
BMI-matched controls. They did not find any significant difference between the 
groups in total energy, macronutrient and micronutrient intake. However, the PCOS 
women had significant more servings of white bread (including white hamburger and 
hot dog buns, muffins and biscuits) and the intake of fried potatoes tended to be 
higher in the PCOS group (148). Our obese pre-PCOS women reported higher intake 
of potatoes and also of the under group fresh potatoes, than the obese women with 
lower FTI score. Another study done on women with PCOS and dietary intake 
reported a higher intake of meat, fish, poultry and eggs among obese PCOS women 
compared to obese women without PCOS (149). We found significant higher 
reported intake among the pre-PCOS of meat and the under group forcemeat, as well 
as the food group consisting of butter, margarine and oils. This may be contributing 
factors to the total fat intake, which tended to be higher among the pre-PCOS women, 
together with a significantly higher intake of polyunsaturated fat. Perhaps the higher 
fat intake is a factor which plays a role in the development of greater body weight of 
the obese pre-PCOS women compared to the obese women with FTI < 0.6. 
Interestingly, the pre-PCOS reported a higher intake of the same food items (except 
potatoes) which constituted a difference between the diets of morbidly obese women 
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and normal weight women. Carefully, we might assume that the intake of these 
particularly food items might be a contributing factor to the development of obesity 
and perhaps PCOS. Previously, dietary histories from American women with PCOS 
were compared to dietary histories from Italian women with PCOS. The American 
women had an average BMI 40.3, while the Italian women had a mean BMI of 29.7. 
The total reported caloric intakes, as well as the proportions of the main dietary 
constituents were similar in the two groups. However, the amount of saturated fat was 
significantly higher among the American women than the Italian. Together with 
genetic and lifestyle factors, the researches concluded that this higher consumption of 
saturated fat may have played a role in the development of excessive weight among 
the American PCOS women (150). 
5.2  PCOS women and effect of weight loss – preliminary 
results of the FEMIN study  
5.2.1 Effects of low-calorie-diet among PCOS women 
The crisp bread diet and the powder diet were high-protein diets, yielding 32.4 % and 
42 %, respectively, of the total energy intake from protein. Furthermore, they were 
low in fat, having an energy percent from fat of 13.5 % and 18.9 %, respectively of 
the total energy intake. With these contributions of energy from protein and fat, the 
powder diet was low in carbohydrate as well (38.8 E %), while the crisp bread diet 
had a carbohydrate content in a more “normal” range (53.1 %). However, such 
composition of low-calorie-diets have previously demonstrated weight reduction 
among obese persons (99;105). 
Effect of LCD on anthropometric measurements 
At baseline, nine women diagnosed with PCOS had a mean BMI of 40, waist 
circumference of 121 cm, hip circumference of 131 cm and a waist-to-hip ratio of 
0.93. Compared to anthropometric measures of morbidly obese women (mean BMI 
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47) reported by Ozenoglu et al, our PCOS women had wider waist circumference, 
lower hip circumference and a more unfavourable waist-to-hip ratio (42). 
Interestingly, our PCOS women had lower mean BMI than the other morbidly obese 
women, still they had wider waist circumference. Among the pre-PCOS women in 
the MOBIL-study we also detected a significant higher waist circumference 
compared to the non-pre-PCOS women. This is accordance with findings from 
Cascella et al, who reported significant higher waist circumference and amount of 
visceral fat among overweight women with PCOS, compared to BMI-matched 
controls (71).  
After the weight reduction intervention period, the participating PCOS women 
significantly reduced their weight, BMI, waist- and hip circumferences. The extent of 
the reductions is in accordance with a previous report on a low-calorie-diet lasting for 
eight weeks among PCOS women (151).    
König et al reported a reduction in waist circumference per kilogram loss of body 
weight to be 0.96 cm/kg in a group of pre-obese/obese women who used a diet 
consisting of meal replacements (ca 1000 kcal/day) in six weeks (152). Our women 
lost an average of 7.4 kg during the weight reduction period, and the waist 
circumferences were lowered by an average of 5.9 cm. This gives a reduction of 0.80 
cm in waist circumference per one lost kilogram body weight.   
Neck circumference is a new risk factor that may reflect risk of the metabolic and 
PCOS syndromes in premenopausal obese women. A neck circumference below 39 
cm indicates a low risk; while a circumference above 42 cm reflect a higher risk. Our 
PCOS women had at baseline a mean neck circumference of 40.3, which indicated 
that they had a intermediate risk to develop the metabolic syndrome (129). However, 
after the low-calorie-diet period, our PCOS women significantly reduced their neck 
circumference with 1.5 cm, to 38.8 cm. According to reference values given by 
Dixon et al, our PCOS women may therefore have reduced their risk of metabolic 
syndrome from intermediate to low (129).   
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Effect of LCD on body composition  
After eight weeks on the low-calorie-diet the PCOS women lost in average 7.4 kg of 
the total body weight, representing a 6.3 % reduction. Loss of fat mass was 5.6 kg, 
representing a 9.7 % reduction in the total fat mass. The women lost 1.9 kg (3.1%) of 
fat free mass, constituting 25.1 % of the total weight loss. Our findings are in 
accordance with a previous study by Moran et al who explored the effect of meal 
replacements, where PCOS patients followed an energy-restricted diet (1100-1200 
kcal/day) for eight weeks, in which two meals per day were replaced by a meal 
replacement. These women lost in average six kg, reduced their total fat mass with 
approximately 12.3 % and lost about 2.5 % of the total fat-free body mass after eight 
weeks intervention (151).  
The observed reduction in fat free mass (25.1 % of total weight loss) is also 
consistent with the findings of Janssen et al, who reported a percentage loss of fat free 
mass of 25.2 of the total weight loss in obese women after LCD (-1000 kcal/day, 16 
weeks), without additional exercise (102). Chaston et al referred to three randomized 
clinical trials which used low-calorie-diets (restricted calorie intake by 1000 kcal/day) 
for 16 weeks, and these subjects lost 27.8 % of the total weight loss as fat free mass 
(approximately 23 % for women). However, participants who participated in exercise 
lost less fat free mass (100). Our results showing that PCOS women lost muscle mass 
(mean 1.8 kg), are in accordance with former studies using low-calorie-diets without 
additional exercise (100;102). Some of the women reported physical activity during 
the weight reduction phase, while others expressed that they did not have the energy 
and drive to perform physical activity together with the diet. To induce weight loss, 
former studies have shown that diet alone, diet with aerobic exercise and diet with 
resistance exercise lead to the same weight loss. However, the loss of muscle mass 
was decreased in groups who engaged in physical activity, and thereby having a 
better body composition after the weight reduction period (102;153).  
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Effect of LCD on lipid profile 
At baseline in the present study, the participating PCOS women had a mean level of 
total cholesterol of 5.0 mmol/l and mean concentrations of LDL-C, HDL-C and 
triglycerides of 3.2, 1.2 and 1.2 mmol/l respectively. According to the 
recommendations from the National Cholesterol Education Program in USA, our 
women had a borderline value of total cholesterol, the levels of LDL-C were 
elevated, while the concentrations of HDL-C and triglycerides were within the 
recommended range (20). Former studies have stated that women with PCOS are 
characterized by elevated levels of triglycerides, and small, dense LDL particles 
together with lower levels of HDL-C (68;76). Our women did not have unfavourable 
triglyceride values, and the concentration of HDL-C was not (yet) to low. According 
to former reported effects of weight loss (41;93), we did not significantly detect the 
expected decrease in levels of total cholesterol and LDL-C, but the levels of 
triglycerides tended to be reduced after the weight reduction period. Recently, 
Thomsen et al investigated the effect of a low-calorie-diet (1200-1400 kcal) among 
obese women with PCOS. After ten weeks on the diet, the women lost weight and 
significantly reduced their levels of total cholesterol, LDL-C and HDL-C compared 
to the concentrations analysed at baseline (153). The same observation was reported 
by Moran et al together with lowered levels of triglycerides (151). We observed not 
significant reductions in the levels of total cholesterol, LDL-C and HDL-C after the 
low-calorie-diet period. However, we might have detected a significant reduction in 
these parameters if our sample of women had been larger. 
Compared to the 52 overweight PCOS women in a study by Pirwany et al, our 
women had approximately the same values of total cholesterol, triglycerides, LDL-C 
and HDL-C as these women (mean age 28.2, mean BMI 29.4). These overweight 
women were compared to BMI-matched controls, and the PCOS women had higher 
concentrations of triglycerides, but the other parameters were not significantly 
different to the values from the controls. However, as our participants were young 
women below the age of 40, the raised levels of LDL-cholesterol were in accordance 
to the findings from Talbott et al, who detected that young women with PCOS have 
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higher LDL-C concentration than controls (78). Elevated levels of LDL-C are also 
reported by Legro et al, who demonstrated a mean value of LDL-C among 144 obese 
PCOS women to be 3.4 mmol/l. Furthermore, these women had higher HDL-C 
concentration than their obese control women, still the absolute value (0.9 mmol/l) 
was below the recommended cut off value, and lower than the HDL-C level observed 
in our women. Furthermore, the triglyceride values to these women were increased 
compared to the levels we detected in our women, 2.2 mmol/l versus 1.2 (80).   
Effect of LCD on cardiovascular disease risk 
According to the Framingham and the INTERHEART study, some risk factors for 
cardiovascular disease are abnormal lipids, abdominal obesity, hypertension, intake 
of fruit and vegetables together with low physical activity. Our PCOS women tended 
to have an unfavourable lipid profile. According to the recommendations from the 
National Cholesterol Education Program, the level of LDL-C was elevated, while the 
concentration of triglycerides was below the recommended value. The level of HDL-
C was tilting around the lower acceptable concentration of this parameter, which 
again has been shown to be a marker of increased cardiovascular risk (32). 
Furthermore, the PCOS women had increased waist circumferences, which were 
higher than the recommended cut off values for metabolic syndrome (4;20). The 
PCOS women also had slightly raised blood pressure. If we assume that these women 
had the same food intake as the obese women from the MOBIL-study, we know that 
they might have an unsatisfactory intake of fruit and vegetables. Furthermore, none 
of the women did report own high physical activity, during the visits at 
Rikshospitalet. Taken all this into consideration the participating PCOS women 
possessed several of the identified risk factors for cardiovascular disease.  
Former studies are inconsequent in whether women with PCOS have increased risk 
of developing cardiovascular disease than women without this syndrome or not 
(90;91). Cussons et al reported that studies of women with PCOS have detected that 
these women have altered function and structure of the cardiovascular system, 
addressing the risk factors to be the consequence, rather than the PCOS diagnosis 
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alone (76). Lo et al have identified such risk factors for CVD among women with 
PCOS (86), and we have consisting findings among our PCOS women. However, 
Shroff et al investigated asymptomatic coronary atherosclerosis among young obese 
women with PCOS, and found elevated occurrence of atherosclerosis in these women 
compared to obese controls, independent of other known risk factors for CVD (154). 
Furthermore, increased carotid intima-media thickness and reduced flow-mediated 
dilatation are demonstrated in young girls with PCOS, factors which lead to 
premature subclinical atherosclerosis (88;89). If women with PCOS tend to have 
more subclinical atherosclerosis due to this syndrome, together with the occurrence of 
other risk factors for cardiovascular disease, the outbreak of these diseases may occur 
earlier than among other women without the syndrome (67). 
Due to the small number of PCOS women we may not have detected significant 
reductions in some of the risk factors for cardiovascular disease (abnormal lipids, 
abdominal obesity, and hypertension) as we might have seen in a larger selection of 
women. However, we observed reductions in total cholesterol, LDL-C, triglycerides 
and systolic- and diastolic blood pressure, together with a significant reduction in 
waist circumference, which may play an important part in development of better 
cardiovascular health among the PCOS women. Furthermore, during the low-calorie-
diet period the women were urged to consume a considerable amount of fruit and 
vegetables, which may further protect against CVD. 
Effect of LCD on CRP 
Another potential marker for cardiovascular risk; CRP, was elevated among the 
PCOS women. At baseline they had a mean concentration of CRP of 9.3, which is far 
above the cut off level which indicates increased risk for subsequent cardiovascular 
disease (17;36). Reduction in CRP levels have been shown after weight reduction 
(17), however we only observed a slight decrease in this parameter after the low-
calorie-diet. However, Moran et al reported from a group of obese women with 
PCOS and their BMI-matched controls that a weight loss of 4-5 % lead to a decrease 
in CRP levels among the non-PCOS women, but not for the women with PCOS. The 
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researchers suggested that in order to see an improved effect in CRP level and 
achieve equivalent cardiovascular benefit as non-PCOS women, a larger weight loss 
is required in women with PCOS compared to women without PCOS. We observed a 
mean weight loss of 6.3 %, but we did not detect a significantly reduction in CRP 
levels (may be type II error). Future research (for instance the FEMIN study) with a 
larger selection of women may detect improved CRP levels according to this 
percentage of weight reduction. 
Apolipoproteins and risk for cardiovascular disease 
Low-calorie-diet lasting for eight weeks did not reduce the concentration of apoB 
among our PCOS women. However, their concentration of apoB was lower than 
previously described among 64 464 females in a Swedish population (155). Elevated 
levels of apoB have been reported to cause an increase in risk for fatal myocardial 
infarction. With apoB levels around 0.8 g/L, our women had a risk ratio of 1 (35). 
Furthermore, the level of apoA-I was significantly lowered after the low-calorie-diet. 
At baseline our PCOS women had the same concentration of this parameter as the 
Swedish women, reported by Jungner et al (155). Walldius et al described that an 
ApoA-I concentration around 1.5 reduces the relative risk for fatal myocardial 
infarction to approximately 0.55 (45 % reduction). However, after the eight weeks on 
diet, our women reduced their concentration of this parameter to 1.3 g/L. A reduction 
in apoA-I diminishes the protective effect of this parameter (relative risk for fatal 
myocardial infarction closer to 1) (35). The ratio of apoB/apoA-I among the PCOS 
women predicted a relative risk for myocardial infarction to be around 1 (35), and the 
ratio was slightly lower than the observed value in the study of the Swedish 
population (155).  
Effect of LCD on the expression of adipokines 
Compared to the pre-PCOS women from the MOBIL-study, the women in the 
FEMIN-study had lower levels of adiponectin and higher concentration of leptin at 
baseline. Previous research has reported significantly lower levels of adiponectin in 
PCOS women (83;147), together with an inverse correlation of this parameter with 
 116 
BMI and waist circumference (83;85), which may explain the lowered levels of this 
parameter among the PCOS women. After the low-calorie-diet the PCOS women 
improved their leptin concentration significantly which is consistent with de Luis et 
al, who reported a decrease in leptin concentrations even after modest weight 
reduction among obese men and women (156). Glintborg et al reported an increase in 
leptin concentration with increasing BMI (83), and by reducing the BMI among the 
PCOS women we observed a reduction in the leptin levels. With regard to the 
concentration of adiponectin we only observed a small increase in this parameter. 
Weight reduction have been associated with an increase in adiponectin levels, 
however this was described in patients without PCOS (52;83).      
5.2.2 Effect of two different low-calorie-diets among PCOS women 
As expected, we did not observe any significant difference between the achieved 
differences ([Δ], baseline measurements – eight weeks measurements), from the 
baseline measurement to the eight weeks control, between the crisp bread diet and the 
powder diet. 
However, when we compared the eight weeks measurement between the groups, we 
detected differences between the groups, which were not present at baseline, see 
figure 11. The women in the powder diet group had significantly lower 
concentrations of total cholesterol, LDL-C, apoB, and leptin, and the apoB/apoA-I 
ratio was more favourable. Furthermore, the waist circumference tended to be lower 
in the powder diet group at the eight weeks control (data not shown). Statistically 
these results can not be used to predict that the powder diet was more effective than 
the crisp bread diet; it is the delta changes which can indicate such a finding. As 
stated before; the achieved differences (Δ) in the two diet groups were not 
significantly different from each other. However, the significant differences between 
the two groups after eight weeks may indicate a difference, which might have been 
demonstrated, with a larger sample of women in each diet group. These results may 
be regarded as hypothesis-generating for the FEMIN study.  
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Different low-calorie-diets and effects on body composition  
Deibert et al compared weight loss and the body composition between three groups 
following three different weight reduction regimens. They showed that a high-soy-
protein, low-fat diet consisting of meal replacements to some of the meals during the 
day, resulted in a greater weight loss and decrease in fat mass compared to a 
conventional moderate-fat diet. The same diet with high-soy-protein and low fat 
content together with physical activity two times during the week did not create a 
higher weight reduction than the diet alone. The researchers assume that the high 
intake of soy-protein may induce a greater loss of fat mass than reduction of muscle 
mass compared to a standard diet, and may minimize the benefit of physical activity 
by preventing the loss of muscle mass (157). Unfortunately, due to our small sample 
of women, we did not detect any difference in loss of fat free mass between the two 
diet groups. However, in both diets, the protein content was high.  
As we compared the women in the two diet groups after eight weeks, we observed a 
tendency to lower waist circumference among the women in the powder diet group. 
This is not in accordance with a recently published study by Katcher et al. They 
studied both women and men with the metabolic syndrome eating an energy-
restricted diet, high in whole grains compared to the same hypo caloric diet, but with 
refined grain products. Both groups lost weight, but the “whole grain group” had 
greater decrease in percentage abdominal fat and CRP, compared to the “refined-
grain group” (158). 
In the powder diet, 34.4 % of the total energy came from added sugar, compared to 
9.8 % in the crisp bread diet. The second main ingredient in the meal replacements 
shakes was fructose, suggesting that the energy derived from fructose was at least 17 
energy percent. Recently focus has been drawn to the potential unfavourably effects 
of high intake of fructose, which according to recent findings of Stanhope et al, may 
lead to a more unfavourable distribution of abdominal fat (viscerally vs. 
subcutaneous) compared to  intake of glucose, together with a decreased insulin 
sensitivity and promotion of dyslipidemia(110).   
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Total cholesterol and LDL-C; effects of soy protein and dietary fibre? 
The achieved differences (Δ) in levels of total cholesterol and LDL-C were not 
significant different between the two diet groups. However, it seemed like the powder 
diet group women reduced their levels of total cholesterol and LDL-C more, and their 
eight weeks measurements were significantly lower than the eight weeks 
measurements for the crisp bread diet women. The powder diet consisted of meal 
replacements shakes, which contained soy as the source of protein. Anderson et al 
described a better improvement in total cholesterol and LDL-C after a weight 
reduction period consisting of meal replacements based on soy, compared to milk-
based meal replacements (112). In a meta-analysis of the effects of soy protein intake 
on serum lipids, they concluded that the ingestion of soy protein rather than animal 
protein significantly decreased levels of total cholesterol, LDL-C and triglycerides 
(111). Furthermore, from this analyse of 29 studies, they reported that consumption 
of soy protein was associated with a net change (change during the soy diet minus 
change during the control diet) of -0.60 mmol/L in total cholesterol. After ingestion 
of Nutrilett powder, the mean value of total cholesterol, among our four PCOS 
women on this diet, were changed with -0.57 mmol/L. For the concentration of LDL-
C, in the meta-analysis the reported reduction was 0.56 mmol/L, and we observed an 
equal reduction of 0.62 mmol/L among our powder diet women. Interestingly, 
approximately similar reduction in triglyceride values was also reported in the meta-
analysis (-0.15 mmol/L) as we detected in our powder diet women; -0.25 mmol/L. 
These results may indicate that the content of soy protein in the powder diet may 
have importance for achieving a better lipid profile, in addition to the weight loss 
induced by these low-calorie meal replacements.  
However, there is not enough evidence to suggest that the content of soy protein in 
meal replacements alone were responsible for what may as an assumed better lipid 
profile. Former studies have described the potential role of dietary fibre in the 
improvement of serum lipids. The meal replacements as we used, contained a 
considerable proportion of dietary fibre, and in the Nutrilett powder, the dietary fibre 
source is soy fibre. Soy beans consist of both insoluble and soluble fibres (10g and 7g 
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respectively, per 100 g dry weight soy bean), and we assume that the shakes have a 
mixture of both these fibre types. In the crisp bread diet, the dietary fibre content was 
also high, allowing for more fibre-rich vegetables. Rye and vegetables have a varying 
content of soluble and insoluble fibre. However, soluble fibres have been investigated 
in regard to the effect on serum cholesterol levels, and soluble fibres have significant 
hypocholesterolemic effects. RCTs have been reviewed, and consumption of soluble 
fibres is associated with reduction in LDL-cholesterol, without significant changes in 
HDL-cholesterol or triglyceride concentrations (113).  
5.2.3 Low-calorie-diets in clinical practice 
Pros and cons for the crisp bread diet 
The strength with the crisp bread diet is the dietary composition and its proximity to 
healthy food choices, portion sizes and meal pattern, all of which are important 
factors in weight reduction. These factors are of equivocal importance in further 
weight reduction or weight maintenance after the end of the low-calorie-diet. In 
addition, dietary fibre, which is a prominent part of crisp breads and vegetables, has 
bulking action, and increase the satiety due to the “fill effect” in the gastrointestinal 
tractus of this dietary component. In this way consumption of dietary fibre can 
decrease the intake of other food items during a meal, and still lead to satiety. Some 
of the women in the crisp bread diet claimed that they actually thought they were 
“allowed” to eat quite a large amount of food, which probably is caused by the 
bulking action. In addition, vegetables are low in calorie content compared to their 
size and amount eaten. Furthermore, using normal food items in a restricted diet may 
enhance the compliance to diet, due to enhanced palatability and plenty of food items 
options. However, what a person might find challenging with the crisp bread diet is to 
restrict their intake of food within the limits given for the diet. Two crisp breads for 
each meal is a much smaller amount of food for a meal, compared to what morbidly 
obese persons might be used to ingest.  
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The crisp bread diet is also easier to incorporate into everyday life, since it is based 
upon common food items and Norwegian food traditions, and therefore might reduce 
the amount of questions and attention given the “slimming” woman. In this way her 
low-calorie-diet period may progress without interfering too much with her social 
life. This may act relieving for some women; others might want the attention and 
“feed back” to get the drive to progress with the diet.  
Pros and cons for the powder diet 
Meal replacements are an effective, nutritionally adequate short-term strategy for 
reducing weight and improving body composition, quality of life, and metabolic and 
reproductive variables. Meal replacements may be a preferred weight-loss strategy 
for some persons, because they can aid in compliance with and adherence to a low-
calorie- diet. However, what might be very essential is the subject’s attitude to the 
meal replacement at the beginning, together with her former experience with such 
shakes and the taste of these. These are some of the factors which might be predictive 
of the participant’s compliance to the powder diet. Some women were disgusted just 
of the thought of the shakes. However, those who completed the eight weeks period 
with meal replacements were positively surprised by how well this worked out. 
Furthermore, powder diet is easy to manage; you know exactly what you are allowed 
to consume each day. However, it might be experienced as boring and monotonous, 
and unfortunately the participants do not get the practice to choose healthy food, 
learn about right portion sizes and meal pattern as they do with the crisp bread diet. 
However the powder diet may give a “kick-start” to weight reduction, leading to the a 
feeling of “master and command”, which again may promote enhanced motivation to 
proceed with further lifestyle modifications and thereby further weight 
reduction/weight maintenance.  
Which low-calorie-diet should we recommend? 
As experienced during this year with ten women participating in, and nine women 
completing an eight weeks period of two different low-calorie-diets, we would 
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indulge our experience to previous published findings (99), that a diet is followed 
with best compliance and results if the person itself is motivated and positively 
directed to the diet in question. Until the results from the FEMIN study is available, 
and until we know if any of the diets give better results among women with PCOS, 
we would recommend and practise both diets, letting the patient itself choose which 
diet she thinks may be most advantageous for her. Both the weight reduction phase 
and the kilocalorie-escalation-phase afterwards must be considered and discussed.  
As a clinical nutritionist, our main task will be to ensure nutritionally adequate 
intakes, as former researchers have concluded that while following energy-restricted 
diets to induce weight loss, the incorporation of fortified foods and/ or dietary 
supplements may be needed (159). Furthermore, of similar importance, is to be a 
fellow-being, giving a lot of support, motivation and care. 
5.2.4 Methodological issues 
Part one - Analyses of reported food intake in the MOBIL-study 
Collecting of data 
When using dietary interviews as a measure of energy intake, we do not know 
whether this person is in a weight stable period, in a weight reduction period or in a 
weight gaining period. The estimated food intake may reflect the actual food intake 
for that period, but not the actual food habits the person has during the whole year.  
The strength with a dietary interview based on a FFQ which was used in the MOBIL 
study is that the interviewer follows the FFQ, making the interviews alike. 
Furthermore, the interviewer may help the interviewed subject to remember forgotten 
food intake occasions etc, which may be forgotten or left out, when the subjects fill in 
the FFQ themselves. A disadvantage of the interviewed FFQ is that the interviewer 
may affect the subject in such way that he/she reports a healthier dietary composition 
than actually consumed. Filling in the FFQ by themselves may result in a more 
honest reporting.    
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Another problem in the measurement of food intake in humans is the conversion of 
the information obtained about the everyday food consumption to nutrient and energy 
intake. Errors may come into being, but this error will most likely be alike for all the 
participants.  
Part two - PCOS women and effect of weight loss – preliminary results 
of the FEMIN study 
Sample size  
A limitation with the present study is the reduced/ non-exciting power to detect 
differences between the two low-calorie-diets. In the FEMIN study the inclusion of 
180 women are calculated to give statistically power. However, due to delayed 
approval to recruit PCOS women from Aker University Hospital, together with a 
more slowly recruitment of PCOS women from “Kvinnehelsesenteret”, 
“Kvinneklinikken” at Rikshospitalet University Hospital HF than expected, we ended 
up with a very small selection of women. A total of ten women were included in our 
study, however one of the women did not attend the second visit, so we had one 
“drop out”, and thereby nine participating women. Due to this small sample size our 
study became a preliminary report of the FEMIN study, where we investigated the 
effect on different body and blood parameters of a low-calorie-diet, rather than 
comparing the effects of the two different diets. Drawing a comparison between the 
crisp bread diet and powder diet group became impossible due to the small number of 
women participating, making statistically analyses almost powerless. However, our 
results may indicate trends that might be detected in the FEMIN study.  
Collecting of data 
Anthropometric data were collected by three different persons (Line Kristin Johnson, 
Linn Mari Bjørnådal and myself) in the present study, which may lead to 
measurement errors. Furthermore, the PCOS women were summoned to 
Rikshospitalet after eight weeks on the low-calorie-diet, but not all the women met to 
this arranged meeting. In addition, some of the blood samplings went wrong and the 
woman had to come back for a new sampling. Therefore, some of the women met a 
 123
couple of weeks later than planned, to be anthropometrically measured and giving 
blood samples. At this point these women had ended their low-calorie-diet and had 
carried forward with “normal food” and a higher energy intake. This might have 
given effect on the registered blood parameters and the weight losses, resulting in 
incorrect values of the effects of LCD. This may be especially relevant for the 
powder diet women, where a switch from meal replacements to “normal food” may 
interfere on the results of the powder diet. 
Statistics 
Part one 
We consulted a statistician, Petter Laake, who advised us to use non-parametric test 
for all of the data, since the principal data were non-normally distributed. Further on, 
he recommended us to investigate the normally distributed data which almost reached 
significant differences with a parametric test as well, to find statistic support to the 
tendency we had detected by the non-parametric test. The control group consisted 
only of 20 women, and with such a small group, it is difficult to detect statistically 
significant differences between groups. The power to correctly identify whether or 
not there was a difference between our groups was weakened/impaired due to for one 
thing the use of non-parametric tests, and also the small size of the control group. We 
may have found some non-significant results due to insufficient power.  
Part two 
Since the achieved differences resulting from the low-calorie-diet were normally 
distributed; we used a parametric test to detect any significant changes at eight weeks 
from baseline. When comparing the two diets against each other, the sample size in 
each group became very small. However, still we were recommended by the 
statistician Petter Laake to perform a parametric test on this material. His 
argumentation for this was based on the fact that our number of women in each group 
was small, and therefore impossible to predict the distribution of the data. In addition 
he assumed that we most likely would not detect any significant differences, so we 
could use the parametric test in any case. Laake also supported the non-parametric 
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comparison of the eight weeks measurements between the two LCD groups, to see if 
we could detect small dissimilarities between them, which were not present at 
baseline.  
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6. Conclusion 
6.1 Part one – Analyses of reported food intake in the 
MOBIL-study 
In the present study we found that  
 Morbidly obese women have a more unfavourable lipid profile and expression 
of the adipokines, leptin and adiponectin, compared to healthy normal weight 
control women 
 There was no significant difference in the composition of their diet with regard 
to energy and macronutrient intake between morbidly obese women and 
healthy normal weight control women. The intake of fat and saturated fat 
tended to be higher among the obese women, while the consumption of 
alcohol (beer, wine, and liquor) was significantly lower than among the 
control women. Total intake of food was greater among the obese than the 
control women. Furthermore, the obese women reported a higher intake of 
meat and forcemeat, butter/margarine/oil; light squash and artificially 
sweetened soft drinks compared to the control women.  
 Morbidly obese women underreport their energy intake more than healthy 
normal weight control women, when using PAL of 1.6 among the obese 
women and PAL 1.8 among the control women.  
 Morbidly obese women with free testosterone index score > 0.6 (pre-PCOS) 
have higher weight, height and waist circumference, and a trend to more 
unfavourable concentration of triglycerides and adiponectin, than morbidly 
obese women with an FTI score ≤ 0.6. The reported energy and macronutrient 
intake were equal between the two groups; however, the consumption of total 
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fat tended to be higher in the pre-PCOS group, and the intake of 
polyunsaturated fat was significantly higher.   
6.2 Part two – PCOS women and effect of weight loss – 
preliminary results of the FEMIN study  
The results in the present study indicate that  
 Eight weeks on a low-calorie-diet lead to significant improvement in weight, 
BMI, waist-, hip-, and neck circumferences, together with reduction in fat 
mass and fat free mass (and muscle mass), leading to an improved body 
composition.  
 Eight weeks on a low-calorie-diet tended to improve the triglyceride 
concentration, however it did not lead to significant improvements in levels of 
total cholesterol, LDL-C, HDL-C and apolipoprotein B, but lead to an 
unfavourable significant decrease in apolipoprotein A-I. Eight weeks on LCD 
did not improve CRP level, systolic and diastolic blood pressure significantly.  
  Eight weeks on a low-calorie-diet lead to significant improvement in leptin 
concentrations, however no effect was observed on adiponectin levels. 
 Changes in markers for cardiovascular disease were not different between 
subjects consuming the crisp bread diet and the powder diet of eight weeks 
duration.  
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